
<html lang="en"     class="pb-page"  data-request-id="327ee6e0-191b-4d42-9e02-fd5bdf182da1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm070776b;issue:issue:10.1021/jmcmar.2008.51.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Inhibitors of the v-raf Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) Based on a 2,6-Disubstituted Pyrazine Scaffold" /></meta><meta name="dc.Creator" content="Ion  Niculescu-Duvaz" /></meta><meta name="dc.Creator" content="Esteban  Roman" /></meta><meta name="dc.Creator" content="Steven R.  Whittaker" /></meta><meta name="dc.Creator" content="Frank  Friedlos" /></meta><meta name="dc.Creator" content="Ruth  Kirk" /></meta><meta name="dc.Creator" content="Ian J.  Scanlon" /></meta><meta name="dc.Creator" content="Lawrence C.  Davies" /></meta><meta name="dc.Creator" content="Dan  Niculescu-Duvaz" /></meta><meta name="dc.Creator" content="Richard  Marais" /></meta><meta name="dc.Creator" content="Caroline J.  Springer" /></meta><meta name="dc.Description" content="BRAF, a serine/threonine kinase, plays a key role in the development of certain types of cancer, particularly melanoma. 2-(3,4,5-Trimethoxyphenylamino)-6-(3-acetamidophenyl)-pyrazine, 1, was identi..." /></meta><meta name="Description" content="BRAF, a serine/threonine kinase, plays a key role in the development of certain types of cancer, particularly melanoma. 2-(3,4,5-Trimethoxyphenylamino)-6-(3-acetamidophenyl)-pyrazine, 1, was identi..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 13, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm070776b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm070776b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm070776b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm070776b" /></link>
        
    
    

<title>Novel Inhibitors of the v-raf Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) Based on a 2,6-Disubstituted Pyrazine Scaffold | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm070776b" /></meta><meta property="og:title" content="Novel Inhibitors of the v-raf Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) Based on a 2,6-Disubstituted Pyrazine Scaffold" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0015.jpeg" /></meta><meta property="og:description" content=" BRAF, a serine/threonine kinase, plays a key role in the development of certain types of cancer, particularly melanoma. 2-(3,4,5-Trimethoxyphenylamino)-6-(3-acetamidophenyl)-pyrazine, 1, was identified as a low micromolar (IC50 = 3.5 µM) BRAF inhibitor from a high-throughput screen of a library of 23000 compounds. This compound was chosen as the starting point of a program aimed at developing inhibitors of mutant V600EBRAF. We have already reported on the optimization of the trimethoxyphenylamino moiety of 1. In this paper, we describe the synthesis of a series of compounds derived from 1 with the purpose of optimization of the pyrazine central core and the phenylacetamido moiety in order to increase the potency against V600EBRAF compared to CRAF. The biological activity of the new inhibitors was assessed against mutant V600EBRAF in vitro. Several compounds were identified with IC50s of 300−500 nM for V600EBRAF, and all compounds that were assessed showed selectivity for V600EBRAF compared to CRAF by 5−&gt;86-fold." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm070776b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm070776b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm070776b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm070776b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm070776b&amp;href=/doi/10.1021/jm070776b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 3261-3274</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm701553u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm7015683" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Inhibitors of the v-raf Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) Based on a 2,6-Disubstituted Pyrazine Scaffold</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ion++Niculescu-Duvaz">Ion Niculescu-Duvaz</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Esteban++Roman">Esteban Roman</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+R.++Whittaker">Steven R. Whittaker</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Friedlos">Frank Friedlos</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruth++Kirk">Ruth Kirk</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian+J.++Scanlon">Ian J. Scanlon</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence+C.++Davies">Lawrence C. Davies</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Niculescu-Duvaz">Dan Niculescu-Duvaz</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Marais">Richard Marais</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caroline+J.++Springer">Caroline J. Springer</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: +44 20 8722 4214 . Fax: +44 20 8722 4046. E-mail: <a href="/cdn-cgi/l/email-protection#690a081b060500070c471a191b00070e0c1b29000a1b47080a471c02"><span class="__cf_email__" data-cfemail="67040615080b0e0902491417150e09000215270e041549060449120c">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Cancer Research UK Centre for Cancer Therapeutics at the Institute of Cancer Research.</div><div class="corresp-fn" id="afn2">‡Cancer Research UK Centre for Cell and Molecular Biology at the Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm070776b&amp;href=/doi/10.1021%2Fjm070776b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 3261–3274</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 13, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 June 2007</li><li><span class="item_label"><b>Published</b> online</span>13 May 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 June 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm070776b" title="DOI URL">https://doi.org/10.1021/jm070776b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3261%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DIon%2BNiculescu-Duvaz%252C%2BEsteban%2BRoman%252C%2BSteven%2BR.%2BWhittaker%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D11%26contentID%3Djm070776b%26title%3DNovel%2BInhibitors%2Bof%2Bthe%2Bv-raf%2BMurine%2BSarcoma%2BViral%2BOncogene%2BHomologue%2BB1%2B%2528BRAF%2529%2BBased%2Bon%2Ba%2B2%252C6-Disubstituted%2BPyrazine%2BScaffold%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3274%26publicationDate%3DJune%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm070776b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1616</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm070776b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Inhibitors of the v-raf Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) Based on a 2,6-Disubstituted Pyrazine Scaffold&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ion&quot;,&quot;last_name&quot;:&quot;Niculescu-Duvaz&quot;},{&quot;first_name&quot;:&quot;Esteban&quot;,&quot;last_name&quot;:&quot;Roman&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;R. Whittaker&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Friedlos&quot;},{&quot;first_name&quot;:&quot;Ruth&quot;,&quot;last_name&quot;:&quot;Kirk&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;J. Scanlon&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;C. Davies&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Niculescu-Duvaz&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Marais&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;J. Springer&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;3261-3274&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm070776b&quot;},&quot;abstract&quot;:&quot;BRAF, a serine/threonine kinase, plays a key role in the development of certain types of cancer, particularly melanoma. 2-(3,4,5-Trimethoxyphenylamino)-6-(3-acetamidophenyl)-pyrazine, 1, was identified as a low micromolar (IC50 = 3.5 µM) BRAF inhibitor from a high-throughput screen of a library of 23000 compounds. This compound was chosen as the starting point of a program aimed at developing inhibitors of mutant V600EBRAF. We have already reported on the optimization of the trimethoxyphenylamino moiety of 1. In this paper, we describe the synthesis of a series of compounds derived from 1 with the purpose of optimization of the pyrazine central core and the phenylacetamido moiety in order to increase the potency against V600EBRAF compared to CRAF. The biological activity of the new inhibitors was assessed against mutant V600EBRAF in vitro. Several compounds were identified with IC50s of 300−500 nM for V600EBRAF, and all compounds that were assessed showed selectivity for V600EBRAF compared to CRAF by 5−&gt;86-fo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm070776b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm070776b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm070776b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm070776b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm070776b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm070776b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm070776b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm070776b&amp;href=/doi/10.1021/jm070776b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm070776b" /></input><a href="/doi/pdf/10.1021/jm070776b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (255 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm070776b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm070776b%26sid%3Dliteratum%253Aachs%26pmid%3D18473434%26genre%3Darticle%26aulast%3DNiculescu-Duvaz%26date%3D2008%26atitle%3DNovel%2BInhibitors%2Bof%2Bthe%2Bv-raf%2BMurine%2BSarcoma%2BViral%2BOncogene%2BHomologue%2BB1%2B%2528BRAF%2529%2BBased%2Bon%2Ba%2B2%252C6-Disubstituted%2BPyrazine%2BScaffold%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D11%26spage%3D3261%26epage%3D3274%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=291978" title="Pyrazine">Pyrazine</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">BRAF, a serine/threonine kinase, plays a key role in the development of certain types of cancer, particularly melanoma. 2-(3,4,5-Trimethoxyphenylamino)-6-(3-acetamidophenyl)-pyrazine, <b>1</b>, was identified as a low micromolar (IC<sub>50</sub> = 3.5 µM) BRAF inhibitor from a high-throughput screen of a library of 23000 compounds. This compound was chosen as the starting point of a program aimed at developing inhibitors of mutant <sup>V600E</sup>BRAF. We have already reported on the optimization of the trimethoxyphenylamino moiety of <b>1</b>. In this paper, we describe the synthesis of a series of compounds derived from <b>1</b> with the purpose of optimization of the pyrazine central core and the phenylacetamido moiety in order to increase the potency against <sup>V600E</sup>BRAF compared to CRAF. The biological activity of the new inhibitors was assessed against mutant <sup>V600E</sup>BRAF in vitro. Several compounds were identified with IC<sub>50</sub>s of 300−500 nM for <sup>V600E</sup>BRAF, and all compounds that were assessed showed selectivity for <sup>V600E</sup>BRAF compared to CRAF by 5−>86-fold.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The RAF−MEK−ERK signal transduction cascade is a conserved protein pathway that regulates cell growth, differentiation, and proliferation in response to external stimuli (growth factors, cytokines, or hormones). Phosphorylation of RAF stimulates its serine/threonine activity, triggering sequential phosphorylation of MEK and ERK. ERK further phosphorylates transcription factors such as ELK-1, regulating gene expression and controlling the response of the cell to external factors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> BRAF<a class="ref internalNav" href="#fn3" aria-label="a">a</a><div class="NLM_fn" id="fn3">a<p class="last">Abbreviations: BRAF, v-raf murine sarcoma viral oncogene homologue B1; CRAF, v-raf murine sarcoma viral oncogene homologue C1.</p></div>  is mutated in approximately 7% of human cancers, with particularly high frequency in melanoma (50−70%), ovarian (35%), thyroid (30%), and colorectal (10%) cancers.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> The most common mutation (90%) is valine substitution by glutamic acid at position 600 (V600E). Mutated BRAF shows a 500-fold elevated kinase activity, providing cancer cells with both proliferation and survival signals.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Therefore, mutant BRAF is an important drug target for the treatment of human cancers.</div><div class="NLM_p">The RAF family proteins (A, B, and C) are serine/threonine kinases.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> A number of inhibitors, designed to target CRAF, are known. These include benzylidene oxindoles,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> ZM 336,372,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and sorafenib, <b>2</b>.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> Sorafenib inhibits <sup>V600E</sup>BRAF (IC<sub>50</sub> = 43 nM) and, recently, isoquinolines<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> and triaryl imidazoles have been reported to have good activity against BRAF.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> The most intensively studied RAF inhibitor, sorafenib (launched for renal cell carcinoma [RCC]<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>) failed to show therapeutic activity in the treatment of malignant melanoma despite positive results in RCC. This failure can be attributed to its inability to reach a concentration in melanoma cells sufficient to inhibit <sup>V600E</sup>BRAF. Therefore, more potent <sup>V600E</sup>BRAF inhibitors are required for melanoma patients.</div><div class="NLM_p">High-throughput screening, of a Biofocus library of 23000 compounds, provided us with a lead compound, <b>1</b>, that showed low micromolar potency against isolated <sup>V600E</sup>BRAF enzyme (IC<sub>50</sub> = 3.5 µM) and a tumor cell line driven by mutant BRAF (SRB, G I<sub>50</sub> = 3.6 µM). See Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0016.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Three main structural domains were chosen for optimization of hit <b>1</b>: the trimethoxyphenyl moiety (ring A), the central pyrazine core (ring B), and the acetamidophenyl group (ring C). We have described previously the modifications of ring A.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Those efforts provided a few compounds that exhibited an improved biological profile with respect to the hit <b>1</b>. Herein we focus on the optimization of rings B and C with the aim of improving the inhibitory IC<sub>50</sub> of the series for <sup>V600E</sup>BRAF and examining some key <sup>V600E</sup>BRAF inhibitors thus found for their selectivity compared to CRAF.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Rationale of the Design</h3><div class="NLM_p last">The pyrazine hit <b>1</b> has a chemical structure significantly different from sorafenib and the other BRAF inhibitors. The design of new analogues was guided by medicinal chemistry considerations. The rationale for the synthesis of these compounds was to make inhibitors that are more selective for mutant BRAF compared to CRAF. The most well-known RAF inhibitor, sorafenib, is often described as a BRAF inhibitor, but we find here that it has no selectivity for BRAF. Herein, we describe potent new inhibitors that are much more selective for mutant BRAF compared to CRAF.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> outlines the synthesis of <b>1</b> and related pyrazine analogues (compounds <b>4</b>−<b>13</b>). The amination of 2,6-dichloropyrazine with 3,4,5-trimethoxyaniline furnished the common intermediate <b>3</b>,<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> which was reacted with several boronic acids or esters, via Suzuki coupling,<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> to furnish the final targets. Several procedures were used for Suzuki couplings, with good results, including ligands such as 1,4-bis-(diphenylphosphino)-butane (dppb), 2,2′-bis-(diphenylphosphino)-1,1′-binaphtalene (BINAP), 4,5-bis-(diphenylphosphino)-9,9-dimethylxanthene (Xantphos), dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylaminobiphenyl) or imidazolium salts, and palladium catalyst such as tris-(dibenzylideneacetone)-dipalladium (0) (Pd(0)<sub>2</sub>dba<sub>3</sub>), [1,1′-bis-(diphenyl phosphino)-ferrocene]dichloropalladium (II) complex with DCM 1:1, (PdCl<sub>2</sub>·dppf:DCM 1:1). The use of phase transfer agents such as tetrabutyl ammonium fluoride proved advantageous in some cases. Both conventional and microwave heating were employed.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0017.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(0)<sub>2</sub>dba<sub>3</sub>, BINAP, NaOtBu, toluene, 90 °C; (b) PdCl<sub>2</sub>·dppf:DCM 1:1, DME, Na<sub>2</sub>CO<sub>3</sub> 1M, 90 °C.</p></p></figure></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> General Strategy for the Synthesis of <b>1</b> and Related Compounds</h3><div class="NLM_p">The synthesis of acetamidopyrazine <b>16</b> (see Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) involved an additional acetylation step. 3-Amino-2,6-dibromopyrazine was converted with acetic anhydride to the diamido pyrazine <b>14</b>, which was reacted with 3-acetamidophenylboronic acid via Suzuki coupling. During this process, one amido group was cleaved, giving intermediate <b>15</b>, which in turn was subjected to amination with 3,4,5-trimethoxoxyphenylamine to furnish acetamidopyrazine <b>16</b>. It was found that the Suzuki coupling yielded the 2-bromo-3-acetamido-6-(3-acetamidophenyl)-pyrazine isomer and not the 2-(3-acetamidophenyl)-3-acetamido-6-bromopyrazine isomer. This was ascertained by the analysis of the NOESY spectrum of <b>15</b>, which shows a crossed peak between the singlet of the pyrazine central core and two of the peaks of the phenyl moiety, fully consistent with the expected isomer. Additionally, the 3-acetamido moiety behaved as an isolated system exhibiting no crossed peaks with the rest of the molecule. The other 6-(3-acetamido) group, on the other hand, interacted with the phenyl moiety, giving the expected crossed peaks. Following the NOESY crossed peaks, this last acetamido unit can also be linked to the pyrazine singlet. All these observations confirmed that the compound obtained was the expected isomer, the Suzuki coupling displacing the least hindered bromine.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0018.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Route for the Synthesis of Compound <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ac<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, reflux; (b) 3-acetamidophenyl boronic acid, PdCl<sub>2</sub>·dppf:DCM 1:1, DME, Na<sub>2</sub>CO<sub>3</sub> 1M, 90 °C, microwave; (c) 3,4,5-trimethoxyaniline, Pd<sub>2</sub>(0)dba<sub>3</sub>, Xantphos, NaOtBu, toluene, 110 °C.</p></p></figure><div class="NLM_p">Several modifications to the pyrazine central core were attempted by introduction of heterocycles other than pyrazine (see Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Reaction of 3,4,5-trimethoxyaniline with 3,5-dibromopyridine yielded the corresponding intermediate <b>17</b>. For amination, we used Xantphos (for the dibromo heterocycles), BINAP, dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylaminobiphenyl), or imidazolium ligands with Pd catalysts and conventional or microwave heating. The resulting intermediates were reacted with 3-acetamido-boronic acid under Suzuki conditions to obtain the desired compound <b>18</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0019.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Route for Central-Core Modified Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3,5-dibromopyridine, Pd(0)<sub>2</sub>dba<sub>3</sub>, BINAP, NaOtBu, toluene, 90 °C; (b) PdCl<sub>2</sub>·dppf:DCM 1:1,DME, Na<sub>2</sub>CO<sub>3</sub> 1M, 90 °C.</p></p></figure><div class="NLM_p">We attempted the introduction of a linker (O, N, or S) in between rings B and C to ascertain whether it would be beneficial in increasing the potency of these molecules. Therefore, the synthesis of the diamino analogues (see Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) was carried out from intermediate <b>3</b>, which was converted under harsher amination conditions with microwave or conventional heating to the desired compounds <b>19</b>−<b>25</b>. Higher loadings of ligands and catalysts were used to compensate for the loss of activity of the pyrazine system upon introduction of the first amino group.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0020.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Diamino Analogues<sup>a</sup>.</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) aminoaryl compounds, Pd(0)<sub>2</sub>dba<sub>3</sub>, 1,3-bis-(2,6-di-i-propylphenyl)-4,5-dihydroimidazolium tetrafluoroborate, KOtBu, dioxane, 100 °C, microwave.</p></p></figure></div><div id="sec1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Synthesis of the Analogues with an Oxygen Linker</h3><div class="NLM_p">For the synthesis of the O-linker analogues, two strategies were followed. First, the common intermediate <b>3</b> (see Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) was reacted with the corresponding phenol under microwave heating conditions in the presence of potassium <i>tert</i>-butoxide. The same chemistry was used to synthesize compound <b>30</b> with a −S− linker. However, using this route, the overall yields are low and the purification of the final compounds difficult. Therefore, we took the alternative approach, which involved the reaction of 2,6-dichloropyrazine with the corresponding potassium phenolate and the subsequent coupling of the resulting intermediates (<b>33</b>, <b>33a</b>−<b>51</b>) with 3,4,5-trimethoxyaniline to yield the desired products (<b>52</b>−<b>69</b>).</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0001.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KOtBu, DMF, 90 °C; (b) Pd(0)<sub>2</sub>dba<sub>3</sub>, dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino-biphenyl), NaOtBu, toluene, 90 °C.</p></p></figure><div class="NLM_p last">Several acetamidonaphthyl (4-, 5-, and 6-acetamido isomers) were synthesized in one step from the corresponding commercial amines by treatment with acetic anhydride. The resulting intermediates were reacted with 2,6-dichloropyrazine to produce the corresponding chloropyrazines (<b>50</b>, <b>51</b>), which were subsequently treated with a series of amines to give the desired final targets (<b>70</b>, <b>77</b>−<b>79</b>). The 2(3,4,5-trimethoxyphenylamino)-6-(4-acetamidonaphthyloxy)-pyrazine, <b>76</b>, was obtained by coupling of the intermediate <b>3</b> with the corresponding 4-acetamido-napthol. The oximes (<b>71</b>−<b>75</b>) were obtained by treating the corresponding ketones (<b>58</b>, <b>59</b>, <b>61</b>, <b>68</b>, <b>69</b>) with hydroxylamine in EtOH.</div></div><div id="sec1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Structure−Activity Relationships</h3><div class="NLM_p">The biological activities of the compounds were determined using the determination of the potency against the <sup>V600E</sup>BRAF enzyme in vitro (IC<sub>50</sub>, BRAF). The data are summarized in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Replacement of the Ring C with Unsubstituted Aryl and Heteroaryl Systems</div><p class="last"></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0002.gif" alt="" id="gr8" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0003.gif" alt="" id="gr9" /></img></td></tr></tbody></table></div></div><div class="NLM_p last">We have shown previously <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> that replacement of the methoxy group from ring A with an imidazolyl moiety increased the potency against BRAF to IC<sub>50</sub> < 1µM. In addition, not all 3-methoxy groups are required for activity; equipotent compounds with only two methoxy groups have been synthesized.</div></div><div id="sec1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Modification of Ring C</h3><div class="NLM_p last">There is a complete loss of activity when ring C is a phenyl or naphthyl system (data not shown), whereas replacement of ring C with a pyridine restores the activity (4-pyridyl-, <b>4</b>).</div></div><div id="sec1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Replacement of the Acetamidophenyl Moiety (Ring C) by Simple Scaffolds</h3><div class="NLM_p">Introduction of other substituents in positions 3 and 4 of the phenyl ring C (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) resulted in some interesting observations.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Substitution of the Phenyl Ring C</div><p class="last"></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0004.gif" alt="" id="gr10" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0005.gif" alt="" id="gr11" /></img></td></tr></tbody></table></div></div><div id="sec1_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Substitution in Position 3</h4><div class="NLM_p last">Introduction of an extra methylene group on the 3-acetamido function results in a total loss of activity. None of the substituents replacing the 3-acetamido group is beneficial.</div></div><div id="sec1_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Substituents in Position 4</h4><div class="NLM_p last">Attaching the acetamido moiety in position 4 results in a loss of activity. The only modification that is fully tolerated in this position is the carboxamide function (compound <b>13</b>), which results in a compound active on BRAF.</div></div><div id="sec1_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Modifications of Ring B</h4><div class="NLM_p">To assess the role of the pyrazine ring in binding, the pyrazine central core was replaced by pyridine (see Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). This modification was partially tolerated, resulting compound <b>18</b> being less active against the enzyme. Replacement of the pyrazine ring by other heterocycles such as pyrimidine or pyridazine renders the compounds inactive. Electronic effects might explain the decrease in activity shown by the pyridine compound <b>18</b>. Many kinase inhibitors have a hinge binding motif consisting of a hydrogen donor−hydrogen acceptor pair. The 3-acetamidopyrazine compound <b>16</b> proved to be inactive, possibly due to the steric hindrance of the hinge binding.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Substitution of the Pyrazine Central Core with Other Heterocycles</div><p class="last"></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0006.gif" alt="" id="gr12" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0007.gif" alt="" id="gr13" /></img></td></tr></tbody></table></div></div></div><div id="sec1_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Linkers between Rings B and C</h4><div class="NLM_p">Three different linkers, −N−, −O−, and −S−, were explored between the central core (pyrazine ring B) and the phenyl ring C (see Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Introduction of an −NH− group as linker between rings B and C (compound <b>22</b>, see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) offered no improvement over hit <b>1</b>, the equivalent with an −N− linker of the hit, was less active.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Introduction of Substituents an −N− Linker between Rings B and C</div><p class="last"></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0008.gif" alt="" id="gr14" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0009.gif" alt="" id="gr15" /></img></td></tr></tbody></table></div></div><div class="NLM_p"><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Introduction of an −O− Linker between Rings B and C</div><p class="last"></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0010.gif" alt="" id="gr16" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0011.gif" alt="" id="gr17" /></img></td></tr></tbody></table></div></div></div><div class="NLM_p">An oxygen atom as linker was also investigated (see Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) by using substituted phenyl rings, fused rings (1- and 2-naphthyl, quinolines, indanones, tetralones, etc.), and biphenyl systems as ring C. Regarding phenyl substitution, hydrophobic atoms such as F and Cl resulted in a decrease of potency with respect to the hit. Introduction of groups able to establish hydrogen bond interactions did not produce any improvement. The most promising systems turned out to be fused rings, especially the 1-naphthyloxy substituent (compound <b>26</b>), which is more potent on BRAF than hit <b>1</b>. By contrast, the 2-naphthyloxy derivative <b>26a</b> was devoid of activity. The most inhibitory BRAF compounds are the 4- and 5-acetamido-naphthyl-1-oxy derivatives <b>76</b> and <b>70</b> with IC<sub>50</sub> of 410−560 nM (see Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Combination of the Core with the Best Rings B and C</div><p class="last"></p></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0014.gif" alt="" id="gr18" /></img></td></tr></tbody></table></div></div><div class="NLM_p">A number of oximes were also synthesized (compounds <b>71</b>−<b>75</b>). They are more active than the precursor ketones, but none of them yield an inhibition of BRAF below 1 µM. Finally, we synthesized a number of compounds combining the most effective structural feature resulting from the foregoing SAR studies on rings A, B, and C (compounds <b>77</b>−<b>79</b>). The most effective compound (<b>79</b>) shows an IC<sub>50</sub> of 310 nM.</div><div class="NLM_p">Sorafenib was originally identified as an inhibitor of CRAF and subsequently found to inhibit mutant BRAF among other kinases.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Sorafenib is reportedly 6-fold more potent against CRAF than it is against <sup>V600E</sup>BRAF. Therefore, we sought to generate inhibitors that were capable of preferentially inhibiting <sup>V600E</sup>BRAF compared to CRAF in order specifically to target oncogenic BRAF. Compounds were tested for activity in a CRAF kinase assay and a selectivity index for inhibition of oncogenic BRAF over CRAF was calculated (see Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). In contrast to sorafenib, which in our hands displayed equal potency against both BRAF and CRAF, all pyrazine compounds tested proved to be 5−>86-fold more selective for BRAF compared to CRAF.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Comparison of Compound Activity vs <sup>V600E</sup>BRAF and CRAF<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compoundnumber</th><th align="center" valign="middle" char="."><sup>V600E</sup>BRAFIC<sub>50</sub> (µM)</th><th align="center" valign="middle" char=".">CRAFIC<sub>50</sub> (µM)</th><th align="center" valign="middle" char=".">selectivityindex</th></tr></thead><tbody><tr valign="top"><td align="left">sorafenib</td><td align="char" char=".">0.043</td><td align="char" char=".">0.052</td><td align="char" char=".">1</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="char" char=".">1.16</td><td align="char" char=".">>100</td><td align="char" char=".">>86</td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="char" char=".">1.12</td><td align="char" char=".">38.15</td><td align="char" char=".">34</td></tr><tr valign="top"><td align="left"><b>76</b></td><td align="char" char=".">0.56</td><td align="char" char=".">20.26</td><td align="char" char=".">36</td></tr><tr valign="top"><td align="left"><b>77</b></td><td align="char" char=".">0.65</td><td align="char" char=".">6.96</td><td align="char" char=".">11</td></tr><tr valign="top"><td align="left"><b>79</b></td><td align="char" char=".">0.31</td><td align="char" char=".">1.52</td><td align="char" char=".">5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">A selectivity index was calculated (CRAF IC<sub>50</sub>/<sup>V600E</sup>BRAF IC<sub>50</sub>) to indicate selectivity of compounds for oncogenic BRAF over CRAF.</p></div></div></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A 2,6-disubstituted pyrazine scaffold selected from a high-throughput screen led to a series of new inhibitors of <sup>V600E</sup>BRAF. Pyrazine inhibitors with potency <500 nM and 5−86-fold more selective for mutant BRAF compared to CRAF have now been obtained.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All starting materials, reagents, and solvents for reactions were reagent grade and used as purchased. Chromatography solvents were HPLC grade and were used without further purification. Reactions were monitored by thin layer chromatography (TLC) analysis using Merck Silica Gel 60 F-254 thin layer plates. Flash column chromatography was carried out on Merck silica gel 60 (0.015−0.040 mm) or in disposable Isolute Flash Si and Si II silica gel columns. Preparative TLC was performed on either Macherey−Nagel (809 023) precoated TLC plates SIL G-25 UV<sub>254</sub> or Analtech (2015) precoated preparative TLC plates, 2000 μm with UV<sub>254</sub>. LC-MS analyses were performed on a Micromass LCT/Waters Alliance 2795 HPLC system with a Discovery 5 µm, C18, 50 mm × 4.6 mm i.d. column from Supelco at a temperature of 22 °C using the following solvent system: solvent A, methanol; solvent B, 0.1% formic acid in water, at a flow rate of 1 mL/min. Gradient starting with 10% A/90% B from 0−0.5 min then 10% A/90% B to 90% A/10% B from 0.5 to 6.5 min and continuing at 90% A/10% B up to 10 min. From 10 to 10.5 min, the gradient reverted back to 10% A/ 90% B and was held until 12 min. UV detection was at 254 nm and ionization was positive or negative ion electrospray. The molecular weight scan range was 50−1000. Samples were supplied as 1 mg/mL in DMSO or methanol with 3 µL injected on a partial loop fill. NMR spectra were recorded in DMSO-<i>d</i><sub>6</sub> on a Bruker DPX 250 operating at 250.13 MHz or on a Bruker Avance 500 operating at 500.26 MHz. The signal of the deuterated solvent was used as internal reference; the chemical shifts are expressed in ppm (δ). Preparative HPLC purifications were performed on an Axial Chromatospac Prep 10 (Jobin-Yvon) using Merck Kieselgel 60 (0.015−0.040). Microwave reactions were run on a CM discovery unit operating at 200 W with simultaneous stirring. The parallel synthesis in liquid phase were run on a Carousel (12 place reaction station) from Radley Discovery Technology.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-pyridyl)-pyrazine (<b>4</b>) (Method A)</h3><div class="NLM_p last">2-(3,4,5-trimethoxyphenylamino)-6-chloropyrazine 3 (200 mg, 0.68 mmol), PdCl<sub>2</sub>.dppf:DCM 1:1 (55 mg, 0.068 mmol) and 4-pyridyl boronic acid (100 mg, 0.82 mmol) were dissolved in DME (15 mL). To this solution, an aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (1.4 mL, 1M) was added under stirring and the reaction mixture was heated at 90 °C for 24 h. After cooling, Et<sub>2</sub>O (25 mL) was added and the organic solution washed with brine (2 × 30 mL), dried (MgSO<sub>4</sub>), and evaporated to dryness. The brown solid obtained was recrystallized from AcOEt, giving the title compound (40 mg). Yield: 17%. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.64 (s, 3H), 3.83 (s, 6H), 7.22 (s, 2H), 8.07 (d, 2H, <i>J</i> = 4.73 Hz), 8.26 (s, 2H), 8.65 (d, 2H,), 8.72 (d, 1H, H<sub>Py</sub>), 9.70 (s, 1H, NH). LC-MS: <i>t</i><sub>R</sub> = 6.20 min; <i>m</i>/<i>z</i>: 339.1 [M<sup>+</sup> + H, 100] calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-pyridyl)-pyrazine (<b>5</b>)</h3><div class="NLM_p last">Using method A (reaction time: 3 h) with 3-pyridylboronic acid (100 mg, 0.82 mmol), the title compound was obtained (120 mg). Yield: 52%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.67 (s, 3H), 3.85 (s, 6H), 7.26 (s, 2H, H), 7.58−7.62 (m, 1H), 8.25 (s, 1H), 8.49 (d, 1H, <i>J</i> = 7.9 Hz), 8.63 (s, 1H), 8.69 (d, 1H, <i>J</i> = 3.2 Hz), 9.51 (d, 1H, <i>J</i> = 2.2 Hz), 9.69 (s, 1H, NH). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ 55.41, 60.20, 96.20, 123.79, 124.40, 129.80, 130.40, 132.50, 133.70, 134.59, 137.00, 145.49, 147.65, 150.20, 151.99, 152.90. LC-MS: <i>t</i><sub>R</sub> = 6.19 min; <i>m</i>/<i>z</i>: 339.1 [M<sup>+</sup> + H, 100] calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>, 339.1457; found, 339.1445.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-hydroxyphenyl)-pyrazine (<b>6</b>) (Method B)</h3><div class="NLM_p last">In an oven-dried flask, the catalyst is prepared by adding under stirring and Ar atmosphere dppb (40 mg, 0.09 mmol) and PdCl<sub>2</sub>(benzonitrile)<sub>2</sub> (30 mg, 0.077 mmol) to dry toluene (10 mL). After 30 min, <b>2</b> (112 mg, 0.38 mmol), 3-(4,4,5,5-tetramethyl-1,3,2-dioxoborolan-2-yl)-phenol (100 mg, 0.45 mmol), EtOH (1.60 mL), and an aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (1.5 mL, 1M) in toluene (10 mL) were added and the reaction mixture was heated at 90 °C for 16 h. After cooling, AcOEt (50 mL) was added to the reaction, and the mixture was washed (2 × 100 mL), dried (MgSO<sub>4</sub>), and evaporated to dryness. The solid obtained was purified by preparative HPLC (Kieselgel 60, 0.015−0.043; eluent: AcOEt) to furnish the title compound (74 mg). Yield: 55%. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.63 (s, 3H), 3.82 (s, 6H), 6.87 (d, 1H, <i>J</i> = 9.8 Hz), 7.25 (s, 2H), 7.29 (t, 1H, <i>J</i> = 9.5 Hz), 7.52 (d, 1H, <i>J</i> = 6.5 Hz), 7.53 (s, 1H), 8.14 (s, 1H), 8.43 (s, 1H), 9.54 (s, 1H, OH), 9.59 (s, 1H, NH). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.61, 60.11, 95.70, 113.28, 116.46, 117.14, 129.80, 131.90, 133.44, 136.90, 138.04, 147.73, 151.38, 152.79, 157.87. LC-MS: <i>t</i><sub>R</sub> = 7.04 min; <i>m</i>/<i>z</i>: 354.5 [(M + H)<sup>+</sup>, 100] calcd for (C<sub>19</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>). HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>, 354.1454; found, 354.1425.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-hydroxyphenyl)-pyrazine (<b>7</b>)</h3><div class="NLM_p last">Using method B (reaction time: 48 h) with 4-(4,4,5,5-tetramethyl-1,3,2-dioxoborolan-2-yl)phenol (242 mg, 1.10 mmol), the title compound was obtained (83 mg). Yield: 60%. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.63 (s, 3H), 3.82 (s, 6H), 6.88 (d, 2H, <i>J</i> = 8.5 Hz), 7.24 (s, 2H), 7.97 (d, 1H, <i>J</i> = 8.7), 8.05 (s, 1H), 8.40 (s, 1H), 9.46 (s, 1H, OH), 9.82 (s, 1H, NH). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.59, 60.11, 95.65, 96.22, 115.60, 127.37, 127.88, 129.02, 131.82, 132.06, 132.20, 133.27, 134.89, 136.72, 140.98, 147.89, 151.32, 152.37, 152.78, 158.90. LC-MS: <i>t</i><sub>R</sub> = 6.90 min; <i>m</i>/<i>z</i>: 354.4 [(M + H)<sup>+</sup>, 100] calcd for C<sub>19</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>, 354.1454; found, 354.1444.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-hydroxymethylphenyl)pyrazine (<b>8</b>)</h3><div class="NLM_p last">Using method B with 4-hydroxy-methylphenyl boronic acid (131 mg, 0.86 mmol), the title compound was obtained (22 mg). Yield: 8%. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d<sub>6</sub></i>) δ: 3.69 (s, 3H), 3.90 (s, 6H), 4.57 (d, 2H, <i>J</i> = 5.7 Hz), 5.28 (t, 1H, <i>J</i> = 5.7 Hz), 7.26 (s, 2H), 7.45 (s, 2H, <i>J</i> = 8.2 Hz), 8.10 (d, 1H), 8.14 (s, 1H), 8.51 (s, 1H), 9.56 (s, 1H, NH). LC-MS: <i>t</i><sub>R</sub> = 6.84 min; <i>m</i>/<i>z</i>: 368.1 [(M + H)<sup>+</sup>, 100] calcd for C<sub>20</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>, 368.1610; found, 368.1606.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-(3,4,5-Trimethoxyphenylamino)-6-(ethyl,3-benzoate)-pyrazine (<b>9</b>)</h3><div class="NLM_p last">Using method B (reaction time: 3 h) with ethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxoborolan-2-yl)-benzoate (450 mg, 1.63 mmol), the title compound was obtained (391 mg). Yield: 70%. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.34 (t, 3H, C<i>H</i><sub>3</sub>CH<sub>2</sub>, <i>J</i> = 7.1 Hz), 3.64 (s, 3H), 3.81 (s, 6H), 4.36 (q, 2H, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 7.22 (s, 2H), 7.67 (t, 1H, <i>J</i> = 7.8 Hz), 8.05 (d, 1H, <i>J</i> = 7.2 Hz), 8.20 (s, 1H), 8.36 (d, 1H, <i>J</i> = 7.8 Hz), 8.57 (s, 1H), 8.68 (s, 1H), 9.63 (s, 1H, NH). LC-MS: <i>t</i><sub>R</sub> = 8.65 min; <i>m</i>/<i>z</i>: 410.1 [(M + H)<sup>+</sup>, 100] calcd for C<sub>22</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub>, 410, 1710; found, 410,1720.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-formylphenyl)-pyrazine (<b>10</b>)</h3><div class="NLM_p last">Using method A with 4-formylphenylboronic acid (123 mg, 0.82 mmol), the title compound was obtained (153 mg). Yield: 62%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.64 (s, 3H), 3.83 (s, 6H), 7.25 (s, 2H), 8.05 (d, 2H, <i>J</i> = 8.2 Hz), 8.23 (s, 1H), 8.35 (d, 2H), 8.64 (s, 1H), 9.68 (s, 1H, NH), 10.08 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.62, 60.12, 96.00, 126.97, 129.93, 130.68, 132.25, 132.87, 136.53, 136.64, 142.10, 146.30, 151.50, 152.84, 192.70. LC-MS: <i>t</i><sub>R</sub> = 7.34 min; <i>m</i>/<i>z</i>: 366.1 [(M + H)<sup>+</sup>, 100] calcd for C<sub>20</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>, 366.1454; found, 366.1458.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-phenylamino)-pyrazine (<b>11a</b>)</h3><div class="NLM_p last">Using method A (reaction time: 18 h) with 4-(4,4,5,5-tetramethyl-1,3,2-borolan-2-yl)-aniline (500 mg, 1.69 mmol), the title compound was obtained (350 mg). Yield: 59%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.63 (s, 3H), 3.82 (s, 6H), 5.53 (s, 2H, NH<sub>2</sub>), 6.64 (d, 2H, <i>J</i> = 8.6 Hz), 7.24 (s, 2H), 7.84 (d, 2H), 7.95 (s, 1H), 8.34 (s, 1H), 9.38 (s, 1H, NH). LC-MS: <i>t</i><sub>R</sub> = 4.08 min; <i>m</i>/<i>z</i>: 352.9 [(M + H)<sup>+</sup>, 100] calcd for C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub>.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-{4-[6-(3,4,5-Trimethoxyphenylamino)-pyrazin-2-yl]phenyl}−3-phenyl urea (<b>11</b>)</h3><div class="NLM_p last">To 200 mg of 2-(3,4,5-trimethoxyphenylamino)-6-(4-phenylamino)-pyrazine (<b>11a</b>) dissolved in dry THF 68 mL (0.60 mmol) of phenyl isocyanate were added under stirring at 40 °C (block). After 20 h, the reaction mixture was evaporated under vacuum and the residue was recrystallized from AcOEt, when 130 mg of a yellow solid were obtained. Yield: 49%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.65 (s, 3H), 3.85 (s, 6H), 7.00 (t, 1H), 7.26 (s, 2H), 7.32 (s, 2H, <i>J</i> = 7.6 Hz), 7.48 (d, 2H), 7.60 (s, 2H, <i>J</i> = 8.7 Hz), 8.08 (d, 2H), 8.11 (s, 1H), 8.42 (s, 1H), 8.42 (s, 1H), 8.73 (s, 1H, NH<sub>urea</sub>), 8.92 (s, 1H, NH<sub>urea</sub>), 9.53 (s, 1H, NH). LC-MS: <i>t</i><sub>R</sub> = 7.05 min; <i>m</i>/<i>z</i>: 421.2 [(M + H)<sup>+</sup>, 100] calcd for C<sub>26</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>26</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>, 472.1979; found, 472.1978.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-cyanophenyl)-pyrazine (<b>12</b>)</h3><div class="NLM_p last">Using method A (reaction time: 18 h) with 3-(4,4,5,5-tetramethyl-1,3,2-borolan-2-yl)-benzonitrile (188 mg, 0.82 mmol), the title compound was obtained (44 mg). Yield: 18%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.64 (s, 3H), 3.84 (s, 6H), 7.23 (s, 2H), 7.73 (t, 1H, <i>J</i> = 7.9 Hz), 7.93 (d, 1H, <i>J</i> = 7.7 Hz), 8.22 (s, 1H), 8.45 (d, 1H, <i>J</i> = 8.0 Hz), 8.57 (s, 1H), 8.64 (s, 1H), 9.68 (s, 1H, NH). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.62, 60.12, 96.00, 112.08, 118.46, 129.93, 130.10, 130.82, 132.25, 132.77, 134.84, 136.60, 137.79, 145.38, 151.43, 151.56, 152.82. LC-MS: <i>t</i><sub>R</sub> = 7.52 min; <i>m</i>/<i>z</i>: 363.1 [(M + H)<sup>+</sup>, 100] calcd for C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>, 363.1457; found, 363.1459.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-carboxamidophenyl)pyrazine (<b>13</b>)</h3><div class="NLM_p last">In a tube suitable for microwave and under Ar were placed <b>3</b> (150 mg, 0.51 mmol), 4-aminocarbonylphenylboronic acid (108 mg, 0.66 mmol), Pd<sub>2</sub>(0)dba<sub>3</sub> (30 mg, 0.051 mmol), 1,3-bis(2,6-di-<i>i</i>-propylphenyl)-4,5-dihydro-imidazolium tetrafluoroborate (24 mg, 0.051 mmol), <i>tetra</i>-<i>n</i>-butylammonium bromide (16.8 mg, 0.051 mmol), and toluene (3 mL). The temperature was lowered to 0 °C and dropwise addition of a suspension of potassium methoxide (106.8 mg, 1.53 mmol) in MeOH (1.2 mL) followed. This mixture was stirred for 5 min at 0 °C, and then microwave irradiation for 30 min at 65 °C followed. The reaction mixture was dissolved in boiling AcOEt (75 mL) and filtered. The resulting organic layer was evaporated under vacuum to give a solid that gave, upon column chromatography (AcOEt), 124 mg of the title compound. Yield: 64%. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.65 (s, 3H), 3.85 (s, 6H), 7.27 (s, 2H), 7.47 (bs, 1H, CONH<sub>2</sub>), 8.02 (d, 2H, <i>J</i> = 8.4 Hz), 8.08 (bs, 1H, CONH<sub>2</sub>), 8.21 (s, 1H), 8.23−8.34 (m, 3H), 8.61 (s, 1H), 9.64 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.61, 60.14, 95.93, 126.15, 127.99, 130.27, 132.14, 134.23, 134.89, 136.76, 139.12, 146.73, 151.47, 152.83, 167.31. LC-MS: <i>t</i><sub>R</sub> = 5.87 min; <i>m</i>/<i>z</i>: 381.1 (M + H)<sup>+</sup> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>, 381.1563; found, 381.1570.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-<i>N</i>,<i>N</i>-Diacetylamido-3,5-dibromo-pyrazine (<b>14</b>)</h3><div class="NLM_p last">2-Amino-3,5-dibromo-pyrazine (1.01 g, 4.0 mmol) and sodium bicarbonate (1.02, 12mmol) were refluxed in acetyl chloride (20 mL) for 2 days. The solvent was evaporated, and the residue was partitioned between DCM and water. The organic layer was dried and evaporated to give 1.31 g of title compound as crystals. Yield: 97%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.26 (6H, s), 9.00 (1H, s). MS <i>m</i>/<i>z</i> (electrospray): 358/60/2 (M + Na<sup>+</sup>).</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-Bromo-3-acetamido-6-(3-acetamidophenyl)-pyrazine (<b>15</b>)</h3><div class="NLM_p last">In a microwave tube under stirring and an Ar atmosphere were placed <b>14</b> (200 mg, 0.59 mmol), 3-acetamidobenceneboronic acid (106 mg, 0.59 mmol), PdCl<sub>2</sub>·dppf:DCM 1:1 complex (36 mg, 0.045 mmol), DME (3.0 mL), H<sub>2</sub>O (0.6 mL), and Na<sub>2</sub>CO<sub>3</sub> (126 mg, 1.19 mmol). The tube was heated by microwave irradiation at 90 °C for 30 min. Two batches were combined, filtered, and the precipitate washed with hot AcOEt (60 mL). The organic layer was evaporated under vacuum, and the resulting crude was chromatographed on silica (AcOEt) to give 26 mg of title compound. Yield: 7%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.07 (s, 3H), 2.12 (s, 3H), 7.46 (t, 1H, <i>J</i> = 7.9 Hz), 7.77 (d, 1H, <i>J</i> = 7.8 Hz), 7.82 (d, 1H, <i>J</i> = 7.7 Hz), 8.21 (bs, 1H), 9.05 (s, 1H), 10.17 (s, 1H), 10.46 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.04, 23.99, 117.03, 120.73, 121.29, 129.54, 134.45, 136.31, 138.55, 140.15, 145.67, 148.90, 168.55, 168.92. LC-MS: <i>t</i><sub>R</sub> = min; <i>m</i>/<i>z</i>: 349.1 (M + H)<sup>+</sup> calcd for C<sub>14</sub>H<sub>13</sub>BrN<sub>4</sub>O<sub>2</sub>.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(3,4,5-Trimethoxyphenylamino)-3-acetamido-6-(3-acetamidophenyl)-pyrazine (<b>16</b>)</h3><div class="NLM_p last">In a microwave tube under stirring and Ar atmosphere were placed <b>15</b> (32 mg, 0.091 mmol), 3,4,5-trimethoxyaniline (33.6 mg, 0.183 mmol), sodium <i>tert</i>-butoxide (18 mg, 0.1833 mmol), Pd(0)<sub>2</sub>dba<sub>3</sub> (8.4 mg, 0.009 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos) (5.3 mg, 0.009 mmol), and dry toluene (1.5 mL). The tube was heated by microwave irradiation at 110 °C for 30 min. The reaction crude was filtered and the precipitate washed with boiling AcOEt (30 mL). The organic layers were evaporated under vacuum, and the resulting crude was chromatographed (AcOEt:EtOH 9:1) to produce the title compound (7 mg). Yield: 17%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.06 (s, 3H), 2.17 (s, 3H), 3.64 (s, 3H), 3.77 (s, 9H), 7.24 (s, 2H), 7.42 (t, 1H, <i>J</i> = 8.0 Hz), 7.64 (d, 1H, <i>J</i> = 7.7 Hz), 7.73 (d, 1H, <i>J</i> = 7.9 Hz), 8.22 (bs, 1H), 8.28 (s, 1H), 8.52 (s, 1H), 10.07 (s, 1H), 10.21 (s, 1H). LC-MS: <i>t</i><sub>R</sub> = 6.20 min; <i>m</i>/<i>z</i>: 452.2 (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>N<sub>5</sub>O5.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 3-(3,4,5-Trimethoxyphenylamino)-5-bromopyridine (<b>17</b>) (Method C)</h3><div class="NLM_p last">To 1.00 g (4.2 mmol) 3,5-dibromopyridine dissolved in 40 mL of dry toluene in an oven-dried flask were added under stirring: Pd(0)<sub>2</sub>dba<sub>3</sub> (82 mg, 0.09 mmol), BINAP (0.168 g, 0.27 mmol), 1.49 g (8.16 mmol) 3,4,5-trimethoxyaniline, and 0.914 g (9.52 mmol) sodium <i>tert</i>-butoxide. The reaction mixture was heated at 90 °C (bath temperature) for 18 h under N<sub>2</sub>. After cooling, the toluene solution was filtered and evaporated in vacuo. The residue was retaken in 30 mL of AcOEt, washed (2 × 30 mL brine), dried, evaporated to a volume of 10 mL, and submitted to HPLC (Kieselgel 60, 0.015−0.043; eluent: AcOEt:cycloxane 2:1). A fraction of 167 mg of the title compound was collected. Yield: 11.7%. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.64 (s, 3H), 3.78 (s, 6H), 6.43 (s, 2H), 7.52 (t, 1H, H<sub>pyr 4</sub>, <i>J</i> = 2.1), 8.04 (d, 1H, <i>J</i> = 1.9 Hz, H<sub>Pyr 2 or 6</sub>), 8.14 (d, 1H, H<sub>Pyr 6 or 2</sub><i>J</i> = 2.3), 8.48 (s, 1H, NH). LC-MS: <i>t</i><sub>R</sub> = 6.28 min; (C<sub>14</sub>H<sub>15</sub>BrN<sub>2</sub>O<sub>3</sub>) <i>m</i>/<i>z</i>: 339.06 [M<sup>+</sup> + 1, 100].</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3-(3,4,5-Trimethoxyphenylamino)-5-(3-acetamidophenyl)-pyridine (<b>18</b>)</h3><div class="NLM_p last">Using method A (reaction time: 4 h) with 3-(3,4,5-trimethoxyphenylamino)-5-bromo-pyridine, <b>25</b>, (160 mg, 0.97 mmol), the title compound was obtained (129 mg). Yield: 70%. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.06 (s, 3H), 3.63 (s, 3H), 3.76 (s, 6H), 6.46 (s, 2H), 7.32 (d, 1H, <i>J</i> = 7.6 Hz), 7.41 (t, 1H, <i>J</i> = 7.8 Hz), 7.54 (d, 1H), 7.58 (m, 1H), 7.95 (s, 1H), 8.24 (s, 1H), 8.34 (s, 1H), 8.46 (s, 1H, NH), 10.11 (s, 1H, NH). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 24.03, 55.76, 60.12, 95.99, 117.19, 118.61, 119.24, 121.39, 129.47, 132.19, 135.86, 137.60, 137.88, 138.02, 138.17, 140.01, 140.70, 153.47, 168.45. LC-MS: <i>t</i><sub>R</sub> = 4.69 min; <i>m</i>/<i>z</i>: 394.1 [(M + H)<sup>+</sup>, 100] calcd for C<sub>22</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>, 394.1767; found, 394.1754.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-acetamidophenylamino)-pyrazine (<b>19</b>) (Method D)</h3><div class="NLM_p last">In a microwave tube, <b>3</b>, (150 mg, 0.51 mmol), 4-aminoacetanilide (114 mg, 0.76 mmol), Pd<sub>2</sub>(0)dba<sub>3</sub> (23 mg, 0.025 mmol), 1,3-bis(2,6-di-<i>i</i>-propylphenyl)-4,5-dihydro-imidazolium tetrafluoroborate (24 mg, 0.051 mmol), potassium <i>tert</i>-butoxide (114 mg, 0.91 mmol), and dioxane (3.5 mL) were reacted under stirring and Ar at 100 °C for 30 min with microwave heating. The reaction mixture was filtered, and the insoluble solid was washed with boiling AcOEt (40 mL). The solution was evaporated under vacuum, and the resulting solid was chromatographed on silica gel using AcOEt as eluent to produce 86 mg of title compound. Yield: 29.8%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.01 (s, 3H), 3.62 (s, 3H), 3.63 (s, 6H), 6.85 (s, 2H), 7.40−7.52 (m, 6H), 9.01 (s, 1H), 9.04 (s, 1H), 9.80 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.82, 55.60, 60.13, 97.01, 119.17, 119.57, 121.33, 121.68, 132.23, 133.28, 136.07, 136.89, 150.22, 152.64, 167.70. LC-MS: <i>t</i><sub>R</sub> = 5.43 min; <i>m</i>/<i>z</i>: 410.2 (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>.</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-(3,4,5-Trimethoxyphenylamino)-6-phenylamino-pyrazine (<b>20</b>)</h3><div class="NLM_p last">Using method D with aniline (71 mg, 0.76 mmol), the title compound was obtained (63 mg). Yield: 35%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.62 (s, 3H), 3.63 (s, 6H), 6.86 (s, 2H), 6.91 (t, 1H, <i>J</i> = 7.3 Hz), 7.22 (t, 2H, <i>J</i> = 9.4 Hz), 7.53 (s, 1H), 7.54 (s, 1H), 7.57 (d, 2H, <i>J</i> = 7.6 Hz), 9.05 (s, 1H), 9.14 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.60, 60.11, 97.01, 118.59, 121.00, 121.87, 121.92, 128.65, 132.26, 136.85, 140.86, 150.00, 150.17, 152.84. LC-MS: <i>t</i><sub>R</sub> = 6.42 min; <i>m</i>/<i>z</i>: 353.1 (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>, 353.1614; found, 353.1612.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-pyridinylamino)-pyrazine (<b>21</b>)</h3><div class="NLM_p last">Using method D with 4-aminopyridine (127 mg, 1.35 mmol), the title compound was obtained (25 mg). Yield: 10%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.64 (s, 3H), 3.68 (s, 6H), 6.83 (s, 2H), 7.55 (d, 2H, <i>J</i> = 6.3 Hz), 7.62 (s, 1H), 7.69 (s, 1H), 8.25 (d, 2H, <i>J</i> = 6.3 Hz), 9.23 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.66, 60.14, 97.52, 112.07, 122.57, 123.96, 132.67, 136.40, 147.39, 148.88, 149.83, 150.18, 152.93. LC-MS: <i>t</i><sub>R</sub> = 3.70 min; <i>m</i>/<i>z</i>: 354.2 (M + H)<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>5</sub>O<sub>3</sub>.</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-acetamidophenylamino)pyrazine (<b>22</b>)</h3><div class="NLM_p last">Using method D with 3-aminoacetanilide (114 mg, 0.76 mmol), the title compound was obtained (12 mg). Yield: 6%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.01 (s, 3H), 3.61 (s, 3H), 3.62 (s, 6H), 6.88 (s, 2H), 7.04 (d, 1H, <i>J</i> = 8.4 Hz), 7.11 (t, 1H, <i>J</i> = 7.9 Hz), 7.50 (d, 1H, <i>J</i> = 7.9 Hz), 7.53 (s, 1 H), 7.56 (s, 1 H), 7.67 (bs, 1 H), 9.05 (s, 1 H), 9.13 (s, 1 H), 9.81 (s, 1 H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.98, 55.58, 60.10, 96.74, 109.169, 112.22, 113.55, 121.87, 122.04, 128.74, 132.14, 136.92, 139.68, 141.08, 149.99, 150.18, 152.64, 168.15. LC-MS: <i>t</i><sub>R</sub> = 5.67 min; <i>m</i>/<i>z</i>: 410.1 (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-(3,4,5-Trimethoxybenzylamino)-6-(4-oxyphenylamino)-pyrazine (<b>23</b>)</h3><div class="NLM_p last">4-Hydroxyaniline (58.0 mg, 0.53 mmol), DMF (5 mL), potassium <i>tert</i>-butoxide (67 mg, 0.60 mmol), and K<sub>2</sub>CO<sub>3</sub> (42 mg, 0.3 mmol) were stirred in Ar. After 5 min, 2-chloro-6-(3,4,5-trimethoxyphenylamino)-pyrazine (150 mg, 0.51 mmol) was added and the reaction mixture heated by microwaves (30 min, 110 °C). The reaction mixture was filtered, poured in water (20 mL), and extracted with AcOEt (2 × 20 mL) The organic layer was pooled, dried, and evaporated to a volume of 2−3 mL. After purification by flash chromatography (Isolute column, Flash SiII, 50 g, 150 mL; eluent: AcOEt), 48.9 mg of the title compound were obtained. Yield: 26%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.61 (s, 12H), 6.67 (d, 2H, <i>J</i> = 8.5 Hz), 6.86 (s, 2H), 7.31 (d, 2H), 7.42 (s, 2H), 8.75 (s, 1H, NH), 8.95 (s, 1H, NH), 9.07 (s, 1H, OH). LC-MS: <i>t</i><sub>R</sub> = 4.48 min; <i>m</i>/<i>z</i>: 353.1 [(M + H)<sup>+</sup>, 100] calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub>, 353.1614; found, 3353.1612.</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-fluorophenylamino)-pyrazine (<b>24</b>)</h3><div class="NLM_p last">Using method D with 3-fluoroaniline (150 mg, 1.35 mmol), the title compound was obtained (60 mg). Yield: 23%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.62 (s, 3H), 3.65 (s, 6H), 6.65−6.72 (m, 1H), 6.81 (s, 2H), 7.24 (m, 2H), 7.56 (s, 1H), 7.58 (s, 1H), 7.67 (d, 1H, <i>J</i> = 13.0 Hz), 9.12 (s, 1H), 9.41 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.45, 60.07, 97.24, 106.71, 107.05, 114.04, 122.16, 122.49, 130.14, 132.43, 136.55, 142.71, 142.89, 149.52, 150.10, 152.89. LC-MS: <i>t</i><sub>R</sub> = 6.75 min; <i>m</i>/<i>z</i>: 371.1 [(M + H)<sup>+</sup>, 100] calcd for C<sub>19</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>3</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>3</sub>, 371.1519; found, 371.1528.</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-fluorophenylamino)-pyrazine (<b>25</b>)</h3><div class="NLM_p last">Using method D with 4-fluoroaniline (150 mg, 1.35 mmol), the title compound was obtained (72 mg). Yield: 28%. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.62 (s, 9H), 6.83 (s, 2H), 7.06 (t, 2H, <i>J</i> = 9.0 Hz), 7.51 (s, 1H), 7.57 (d, 2H, <i>J</i> = 9.1 Hz), 9.05 (s, 1H), 9.14 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.56, 60.12, 97.01, 114.94, 115.29, 120.38, 120.50, 121.62, 121.83, 132.29, 137.19, 137.22, 150.15, 152.84. LC-MS: <i>t</i><sub>R</sub> = 6.38 min; purity > 99%. HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>3</sub>, 371.1519; found, 371.1522.</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-(3,4,5-Trimethoxyphenylamino)-6-(naphthalen-1-yloxy)-pyrazine (<b>26</b>) (Method E)</h3><div class="NLM_p last">In a microwave tube were mixed under Ar and stirring, 1-naphthol (73 mg, 0.51 mmol), K<sub>2</sub>CO<sub>3</sub> (35 mg, 0.25 mmol), potassium <i>tert</i>-butoxide (60 mg, 0.53 mmol), and DMF dry (3.5 mL). This mixture was stirred for 10 min, <b>2</b> (150 mg, 0.51 mmol) was added and the tube was heated for 30 min at 120 °C. The reaction crude was mixed with 40 mL of solution NaOH 1.5 M and extracted with DCM (3 × 40 mL). The organic layers were combined, dried (MgSO<sub>4</sub>), filtered, and evaporated under vacuum to give a solid that was chromatographed using DCM:AcOEt (7:3) as eluent to produce the title compound (66 mg). Yield: 32%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.19 (s, 6H), 3.47 (s, 3H), 6.58 (s, 2H), 7.32 (d, 1H, <i>J</i> = 8.5 Hz), 7.50−7.60 (m, 3H), 7.83 (d, 1H, <i>J</i> = 8.3 Hz), 7.91 (s, 1H), 7.96 (s, 1H), 7.98−8.03 (m, 2H), 9.49 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.17, 59.96, 95.53, 117.11, 120.88, 121.28, 124.80, 126.03, 126.54, 126.65, 126.72, 127.96, 128.32, 132.07, 134.45, 136.16, 149.40, 150.61, 152.58, 158.19. LC-MS: <i>t</i><sub>R</sub> = 8.50 min; <i>m</i>/<i>z</i>: (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>, 404.1610; found. 404.1651.</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-(3,4,5-Trimethoxyphenylamino)-6-(naphthalen-2-yloxy)-pyrazine (<b>26a</b>)</h3><div class="NLM_p last">Using method E, with 2-naphthol (73 mg, 0.51 mmol), the title compound was obtained (78 mg). Yield: 38%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.06 (s, 9H), 3.45 (s, 3H), 6.69 (s, 2H), 7.37 (dd, 1H, <i>J</i><sub>1</sub> = 2.3 Hz, <i>J</i><sub>2</sub> = 8.9 Hz), 7.49−7.54 (m, 2H), 7.72 (d, 1H, <i>J</i> = 2.0 Hz), 7.84−7.89 (m, 2H), 7.92−7.99 (m, 3H), 9.55 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 54.81, 59.95, 95.64, 116.83, 121.05, 121.18, 125.53, 126.65, 127.15, 127.61, 128.51, 129.61, 130.45, 132.06, 133.78, 136.25, 150.57, 151.52, 152.57, 157.47. LC-MS: <i>t</i><sub>R</sub> = 8.62 min; <i>m</i>/<i>z</i>: 404.1 (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>, 404.1610; found, 404.1590.</div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-(3,4,5-Trimethoxyphenylamino)-6-(phenyloxy)-pyrazine (<b>27</b>)</h3><div class="NLM_p last">Following procedure E (no K<sub>2</sub>CO<sub>3</sub> added) with phenol (48 mg, 0.51 mmol), the title compound was obtained (127 mg). Yield: 71%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.31 (s, 9H), 3.54 (s, 3H), 6.77 (s, 2H), 7.16−7.23 (m, 3H), 7.41 (t, 2H, <i>J</i> = 7.9 Hz), 7.75 (s, 1H), 7.95 (s, 1H), 9.53 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.33, 60.03, 95.77, 120.55, 121.17, 124.47, 128.42, 129.74, 132.15, 136.29, 150.52, 152.69, 153.86, 153.86, 157.23. LC-MS: <i>t</i><sub>R</sub> = 7.65 min; <i>m</i>/<i>z</i>: 354.1 (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>, 354.1454; found, 354.1444.</div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-pyridinyloxy)-pyrazine (<b>28</b>)</h3><div class="NLM_p last">Using method E with 4-hydroxypyridine (48 mg, 0.51 mmol), the title compound was obtained (89 mg). Yield: 50%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.64 (s, 3H), 3.79 (s, 6H), 6.29 (d, 2H, <i>J</i> = 7.9 Hz), 7.07 (s, 2H), 8.19 (s, 1H), 8.32 (s, 1H), 8.43 (d, 2H, <i>J</i> = 8.0 Hz), 9.91 (bs, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.61, 60.11, 96.50, 117.94, 121.98, 132.71, 132.79, 135.77, 136.52, 145.43, 150.31, 152.85, 178.22. LC-MS: <i>t</i><sub>R</sub> = 5.52 min; <i>m</i>/<i>z</i>: 355.1 (M + H)<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub>, 355.1406; found, 355.1418.</div></div><div id="sec3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-pyridinyloxy)-pyrazine (<b>29</b>)</h3><div class="NLM_p last">Using method E with 3-hydroxypyridine (48 mg, 0.51 mmol), the title compound was obtained (46 mg). Yield: 26%. <sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.41 (s, 6H), 3.54 (s, 3H), 6.71 (s, 2H), 7.47 (m, 1H, <i>J</i><sub>1</sub> = 0.6 Hz, <i>J</i><sub>2</sub> = 4.7 Hz, <i>J</i><sub>3</sub> = 8.4 Hz), 7.69 (m, 1H, <i>J</i><sub>1</sub> = 1.4 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, <i>J</i><sub>3</sub> = 8.4 Hz), 7.82 (s, 1H), 7.98 (s, 1H), 8.43 (dd, 1H, <i>J</i><sub>1</sub> = 1.4 Hz, <i>J</i><sub>2</sub> = 4.7 Hz), 8.54 (dd, 1H, <i>J</i><sub>1</sub> = 0.5 Hz, <i>J</i><sub>2</sub> = 2.8 Hz), 9.61 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.32, 60.04, 95.95, 120.94, 124.52, 128.42, 128.91, 132.34, 136.10, 142.68, 145.66, 150.31, 150.38, 152.71, 156.84. LC-MS: <i>t</i><sub>R</sub> = 6.27 min; <i>m</i>/<i>z</i>: 355.1 (M + H)<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub>, 355.1406; found, 355.1416.</div></div><div id="sec3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-(3,4,5-Trimethoxyphenylamino)-6-(naphthalen-1-ylthio)-pyrazine (<b>30</b>)</h3><div class="NLM_p last">Using method E with 1-thionaphthol (81 mg, 0.51 mmol), the title compound was obtained (68 mg). Yield: 32%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.60 (s, 3H), 3.61 (s, 6H), 6.94 (s, 2H), 7.25 (s, 1H), 7.57−7.63 (m, 3H), 7.91 (s, 1H), 7.95 (dd, 1H, <i>J</i><sub>1</sub> = 1.2 Hz, <i>J</i><sub>2</sub> = 7.1 Hz), 8.03−8.07 (m, 1H), 8.11 (d, 1H, <i>J</i> = 8.3 Hz), 8.26−8.30 (m, 1H), 9.54 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.55, 60.09, 96.41, 124.82, 126.23, 126.58, 126.74, 127.65, 128.90, 129.90, 130.63, 131.09, 132.52, 133.33, 133.97, 134.60, 136.13, 151.27, 152.55, 152.74. LC-MS: <i>t</i><sub>R</sub> = 8.54 min; <i>m</i>/<i>z</i>: 420.1 (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub>S. HRMS: (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub>S, 420.1382; found, 420.1378.</div></div><div id="sec3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-(3,4,5-Trimethoxyphenylamino)-6-(5,6,7,8-tetrahydronaphthalen-1-yloxy)-pyrazine (<b>31</b>)</h3><div class="NLM_p last">Using method E with 5,6,7,8-tetrahydro-1-naphthol (75 mg, 0.51 mmol), the title compound was obtained (27 mg). Yield: 13%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.65−1.69 (m, 4H), 2.53−2.56 (m, 2H), 2.72−2.77 (m, 2H), 3.42 (s, 6H), 3.54 (s, 3H), 6.74 (s, 2H), 6.89 (d, 1H, <i>J</i> = 7.9 Hz), 6.95 (d, 1H, <i>J</i> = 6.6 Hz), 7.11 (t, 1H, <i>J</i> = 7.8 Hz), 7.71 (s, 1H), 7.91 (s, 1H), 9.55 (bs, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 22.01, 22.26, 23.12, 28.78, 55.36, 60.03, 95.72, 118.40, 120.56, 125.66, 126.09, 127.60, 129.06, 132.10, 136.39, 138.76, 150.59, 151.46, 152.70, 157.65. LC-MS: <i>t</i><sub>R</sub> = 8.62 min; <i>m</i>/<i>z</i>: 408.2 (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub>, 408.1923; found, 408.1916.</div></div><div id="sec3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-(3,4,5-Trimethoxyphenylamino)-6-(1<i>H</i>-indol-4-yloxy)-pyrazine (<b>32</b>)</h3><div class="NLM_p last">Using method E with 4-hydroxyindole (67 mg, 0.51 mmol), the title compound was obtained (34 mg). Yield: 17%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.24 (s, 6H), 3.49 (s, 3H), 6.10−6.12 (m, 1H), 6.66 (s, 2H), 6.79 (d, 1H, <i>J</i> = 7.1 Hz), 7.07 (t, 1H, <i>J</i> = 7.8 Hz), 7.25−7.29 (m, 2H), 7.79 (s, 1H), 7.92 (s, 1H), 9.44 (s, 1H), 11.26 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.12, 59.96, 95.43, 98.04, 108.42, 109.87, 120.50, 120.91, 121.37, 125.36, 127.87, 131.91, 136.34, 138.13, 146.33, 150.59, 152.58, 157.84. LC-MS: <i>t</i><sub>R</sub> = 7.22 min; <i>m</i>/<i>z</i>: 393.1 (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>, 393.1563; found, 393.1534.</div></div><div id="sec3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 2-Chloro-6-(quinolin-4-yloxy)-pyrazine (<b>33</b>) (Method F)</h3><div class="NLM_p last">In a carousel tube suitable for parallel synthesis were added 2,6-dichloropyrazine (250 mg, 1.69 mmol), 4-hydroxyquinoline (270 mg, 1.49 mmol), dry degassed DMF (10 mL), and potassium <i>tert</i>-butoxide (165 mg, 1.49 mmol). This mixture was stirred under Ar at 90 °C (block) for 5 h. The reaction mixture was diluted with AcOEt (20 mL), washed with brine (2 × 20 mL), dried, and evaporated under vacuum. Purification by column chromatography (AcOEt:cyclohexane, 1:1) afforded the title compound (60 mg). Yield: 14%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.45 (d, 1H, <i>J</i> = 4.9 Hz), 7.67 (t, 1H, <i>J</i> = 7.6 Hz), 7.86 (t, 1H, <i>J</i> = 7.8 Hz), 8.12 (d, 2H, <i>J</i> = 8.7 Hz), 8.67 (s, 1H), 8.82 (s, 1H), 8.94 (d, 1H, <i>J</i> = 4.9 Hz). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 111.15, 121.39, 121.52, 127.20, 129.11, 130.74, 134.54, 139.24, 144.48, 149.59. 151.42, 156.17, 157.21. LC-MS: <i>t</i><sub>R</sub> = 5.45 min; <i>m</i>/<i>z</i>: 258.0 (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>9</sub>ClN<sub>3</sub>O. HRMS: (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>9</sub>N<sub>3</sub>OCl, 258.0434; found, 258.0427.</div></div><div id="sec3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-Chloro-6-(quinoline-5-oxy)-pyrazine (<b>33a</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (250 mg, 1.69 mmol) and 5-hydroxyquinoline (270 mg, 1.49 mmol). Purification by column chromatography (AcOEt:cyclohexane, 1:1) gave the title compound (264 mg). Yield: 61%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.54−7.58 (m, 2H), 7.84 (t, 1H, <i>J</i> = 8.1 Hz), 8.01 (d, 1H, <i>J</i> = 8.5 Hz), 8.37 (d, 1H, <i>J</i> = 8.0 Hz), 8.55 (s, 1H), 8.73 (s, 1H), 8.98 (dd, 1H, <i>J</i> = 1.4 Hz, <i>J</i> = 4.0 Hz). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 118.19, 121.82, 121.99, 126.94, 129.37, 129.99, 133.76, 137.84, 144.32, 147.74, 148.57. 151.27, 158.57. LC-MS: <i>t</i><sub>R</sub> = 5.71 min; <i>m</i>/<i>z</i>: 258.0 (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>9</sub>ClN<sub>3</sub>O. HRMS: (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>9</sub>N<sub>3</sub>OCl, 258.0434; found, 258.0433.</div></div><div id="sec3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-Chloro-6-(quinoline-6-oxy)-pyrazine (<b>34</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (250 mg, 1.69 mmol) and 6-hydroxyquinoline (270 mg, 1.49 mmol). Purification by column chromatography (AcOEt:cyclohexane, 1:1) afforded the title compound (324 mg). Yield: 75%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.56−7.59 (m, 1H), 7.70 (dd, 1H, <i>J</i><sub>m</sub> = 2.6 Hz, <i>J</i><sub>o</sub> = 9.1 Hz), 7.87 (d, 1H, <i>J</i> = 2.4 Hz), 8.12 (d, 1H, <i>J</i> = 9.0 Hz), 8.37 (d, 1H, <i>J</i> = 8.1 Hz), 8.56 (s, 1H), 8.65 (s, 1H), 8.93 (dd, 1H, <i>J</i> = 1.0 Hz, <i>J</i> = 4.9 Hz). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 117.82, 122.01, 124.48, 128.50, 131.00, 133.86, 135.69, 137.88, 144.41, 145.64, 150.58. 150.38, 158.23. LC-MS: <i>t</i><sub>R</sub> = 6.07 min; <i>m</i>/<i>z</i>: 258.0 (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>9</sub>ClN<sub>3</sub>O. HRMS: (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>9</sub>N<sub>3</sub>OCl, 258.0434; found, 258.0433.</div></div><div id="sec3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-Chloro-6-(isoquinoline-5-oxy)-pyrazine (<b>35</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (250 mg, 1.69 mmol) and 5-hydroxyisoquinoline (270 mg, 1.49 mmol). Purification by column chromatography (AcOEt:cyclohexane, 1:1) furnished the title compound (263 mg). Yield: 61%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.72−7.78 (m, 3H), 8.11 (d, 1H, <i>J</i> = 7.8 Hz), 8.53 (d, 1H, <i>J</i> = 5.9 Hz), 8.55 (s, 1H), 8.75 (s, 1H), 9.43 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 114.05, 122.20, 125.66, 127.72, 128.98, 129.26, 133.78, 137.86, 143.56, 144.26, 146.92. 152.51, 158.45. LC-MS: <i>t</i><sub>R</sub> = 4.94 min; <i>m</i>/<i>z</i>: 258.0 (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>9</sub>ClN<sub>3</sub>O. HRMS: (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>9</sub>N<sub>3</sub>OCl, 258.0434; found, 258.0448.</div></div><div id="sec3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-Chloro-6-(7-coumarinyloxy)-pyrazine (<b>36</b>)</h3><div class="NLM_p last">Using method F with 2,6-dichloropyrazine (200 mg, 1.35 mmol) and 17-hydroxy coumarine (242 mg, 1.49 mmol), 370 mg of the desired compound resulted after purification. Yield: 100%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 6.50 (d, 1H, <i>J</i> = 9.6 Hz), 7.29 (dd, 1H, <i>J</i><sub>o</sub> = 8.2 Hz, <i>J</i><sub>m</sub> = 2.2 Hz), 7.44 (d, 1H, <i>J</i> = 2.2 Hz), 7.84 (d, 1H, <i>J</i> = 8.4 Hz), 8.10 (d, 1H, <i>J</i> = 9.6 Hz), 8.60 (s, 1H), 8.65 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 109.02, 115.37, 115.89, 117.16, 129.86, 134.01, 138.39, 143.79, 144.37, 155.03. 155.35, 157.61, 159.66, 161.27. LC-MS: <i>t</i><sub>R</sub> = 6.30 min; <i>m</i>/<i>z</i>: 275.0 (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>8</sub>ClN<sub>2</sub>O<sub>3</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>8</sub>ClN<sub>2</sub>O<sub>3</sub>, 275.0223; found, 275.0231.</div></div><div id="sec3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2-Chloro-6-(5-tetral-1-onyloxy)-pyrazine (<b>37</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (200 mg, 1.34 mmol) and 5-hydroxy-tetralone (238 mg, 1.49 mmol). Purification by column chromathography (AcOEt:cyclohexane, 1:1) afforded the title compound (366 mg). Yield: 100%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.97−2.07 (m, 2H), 2.64 (t, 2H, <i>J</i> = 7.1 Hz), 2.77 (t, 2H, <i>J</i> = 6.8 Hz), 7.46−7.45 (m, 2H), 7.86 (dd, 1H, <i>J</i><sub>o</sub> = 7.4 Hz, <i>J</i><sub>m</sub> = 1.6 Hz), 8.54 (s, 1H), 8.63 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 21.69, 22.73, 38.05, 124.03, 126.82, 127.38, 133.36, 134.03, 136.79, 137.60, 144.40, 149.80, 157.96, 196.73. LC-MS: <i>t</i><sub>R</sub> = 6.94 min; <i>m</i>/<i>z</i>: 275.0 (M + H)<sup>+</sup> calcd for C<sub>14</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>2</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>14</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>2</sub>, 275.0587; found, 275.0595.</div></div><div id="sec3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-Chloro-6-(6-tetral-1-onyloxy)-pyrazine (<b>38</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (200 mg, 1.34 mmol) and 6-hydroxy-tetralone (238 mg, 1.49 mmol). Crystallization from AcOEt furnished the title compound (365 mg). Yield: 100%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.02−2.12 (m, 2H), 2.63 (t, 2H, <i>J</i> = 5.9 Hz), 2.97 (t, 2H, <i>J</i> = 6.5 Hz), 7.20−7.26 (m, 2H), 7.96 (d, 1H, <i>J</i> = 8.3 Hz), 8.59 (s, 1H), 8.62 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 22.96, 29.92, 38.37, 119.23, 120.46, 128.70, 129.18, 134.08, 138.33, 144.44, 147.14, 156.34, 157.61, 196.35. LC-MS: <i>t</i><sub>R</sub> = 7.03 min; <i>m</i>/<i>z</i>: 275.0 (M + H)<sup>+</sup> calcd for C<sub>14</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>2</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>14</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>2</sub>, 275.0587; found, 275.0592.</div></div><div id="sec3_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 2-Chloro-6-(indanone-4-oxy)-pyrazine (<b>39</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (200 mg, 1.34 mmol) and 4-hydroxyindanone (219 mg, 1.49 mmol). Crystallization from AcOEt afforded the title compound (314 mg). Yield: 90%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.70 (t, 2H, <i>J</i> = 5.7 Hz), 2.94 (t, 2H, <i>J</i> = 5.7 Hz), 7.55−7.64 (m, 3H), 8.57 (s, 1H), 8.66 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 22.43, 35.68, 120.55, 127.24, 129.29, 133.55, 137.88, 139.26, 144.38, 146.50, 149.95, 157.62, 205.32. LC-MS: <i>t</i><sub>R</sub> = 6.48 min; <i>m</i>/<i>z</i>: 275.0 (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>10</sub>ClN<sub>2</sub>O<sub>2</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>10</sub>ClN<sub>2</sub>O<sub>2</sub>, 261.0431; found, 261.0432.</div></div><div id="sec3_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-Chloro-6-(indanone-5-oxy)-pyrazine (<b>40</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (200 mg, 1.34 mmol) and 5-hydroxyindanone (219 mg, 1.49 mmol). Crystallization from AcOEt produced the title compound (350 mg). Yield: 100%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.67 (t, 2H, <i>J</i> = 5.9 Hz), 3.13 (t, 2H, <i>J</i> = 5.5 Hz), 7.31 (dd, 1H, <i>J</i><sub>m</sub> = 1.9 Hz, <i>J</i><sub>o</sub> = 8.3 Hz), 7.47 (d, 1H, <i>J</i> = 1.3 Hz), 7.73 (d, 1H, <i>J</i> = 8.3 Hz), 8.59 (s, 1H), 8.64 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 25.45, 36.11, 120.56, 124.83, 134.07, 138.34, 144.42, 157.76, 204.61. LC-MS: <i>t</i><sub>R</sub> = 6.34 min; <i>m</i>/<i>z</i>: 261.0 (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>10</sub>ClN<sub>2</sub>O<sub>2</sub>.</div></div><div id="sec3_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2-Chloro-6-(indanone-6-oxy)-pyrazine (<b>41</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (200 mg, 1.34 mmol) and 6-hydroxyindanone (219 mg, 1.49 mmol). Crystallization from AcOEt produced the title compound (330 mg). Yield: 94%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.74 (t, 2H, <i>J</i> = 5.8 Hz), 3.15 (t, 2H, <i>J</i> = 6.0 Hz), 7.50 (d, 1H, <i>J</i> = 2.2 Hz), 7.60 (dd, 1H, <i>J</i><sub>m</sub> = 2.3 Hz, <i>J</i><sub>o</sub> = 8.3 Hz), 7.70 (d, 1H, <i>J</i> = 8.3 Hz), 8.53 (s, 1H), 8.59 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 25.13, 36.59, 115.03, 128.01, 128.48, 133.84, 137.57, 138.21, 144.20, 152.51, 158.25, 205.56. LC-MS: <i>t</i><sub>R</sub> = 6.48 min; <i>m</i>/<i>z</i>: 261.0 (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>10</sub>ClN<sub>2</sub>O<sub>2</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>10</sub>ClN<sub>2</sub>O<sub>2</sub>, 261.0431; found, 261.0422.</div></div><div id="sec3_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 2-Chloro-6-(2-phenyl−phenyl-oxy)-pyrazine (<b>42</b>)</h3><div class="NLM_p last">Method F was followed (reaction time: 20 h) with 2,6-dichloropyrazine (200 mg, 1.34 mmol) and 2-phenyl-phenol (268 mg, 1.49 mmol). Purification by column chromatography (AcOEt:cyclohexane, 1:2) produced the title compound (238 mg). Yield: 65%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.31−7.61 (m, 9H), 8.43 (s, 1H), 8.46 (s, 1H). LC: <i>t</i><sub>R</sub> = 8.40 min; <i>m</i>/<i>z</i>: 283.1 (M + H)<sup>+</sup> calcd for C<sub>16</sub>H<sub>11</sub>ClN<sub>2</sub>O.</div></div><div id="sec3_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 2-Chloro-6-(2-fluorophenyl-oxy)-pyrazine (<b>43</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (250 mg, 1.69 mmol) and 2-fluorophenol (166 µL, 1.86 mmol). Purification by column chromathography (AcOEt:cyclohexane, 1:1) afforded the title compound (302 mg). Yield: 80%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.31−7.45 (m, 4H), 8.56 (s, 1H), 8.67 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 116.94, 123.93, 125.47, 127.64, 133.10, 138.02, 144.33, 152.71, 154.68, 157.49. LC-MS: <i>t</i><sub>R</sub> = 7.19 min; <i>m</i>/<i>z</i>: 225.0 (M + H)<sup>+</sup> calcd for C<sub>10</sub>H<sub>6</sub>ClFN<sub>2</sub>O. HRMS: (M + H)<sup>+</sup> calcd for C<sub>10</sub>H<sub>6</sub>ClFN<sub>2</sub>O, 225.0231; found, 225.0222.</div></div><div id="sec3_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 2-Chloro-6-(3-fluorophenyl-oxy)-pyrazine (<b>44</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (250 mg, 1.69 mmol) and 3-fluorophenol (166 µL, 1.86 mmol). Purification by column chromatography (AcOEt:cyclohexane, 1:1) afforded the title compound (347 mg). Yield: 92%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.13−7.17 (m, 2H), 7.25 (d, 1H, <i>J</i><sub>F</sub> = 10.0 Hz), 7.52 (q, 1H, <i>J</i> = 8.1 Hz), 8.54 (s, 1H), 8.56 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 109.15, 112.56, 117.28, 131.17, 133.77, 137.95, 144.34, 153.74, 157.85, 161.35. LC-MS: <i>t</i><sub>R</sub> = 7.31 min; <i>m</i>/<i>z</i>: 224.0 (M)<sup>+</sup> calcd for C<sub>10</sub>H<sub>6</sub>ClFN<sub>2</sub>O.</div></div><div id="sec3_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 2-Chloro-6-(3-chlorophenyl-oxy)-pyrazine (<b>45</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (250 mg, 1.69 mmol) and 3-chlorophenol (193 µL, 1.86 mmol). Purification by column chromatography (AcOEt:cyclohexane, 1:1), afforded the title compound (346 mg). Yield: 85%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.32 (dd, 1H, <i>J</i><sub>o</sub> = 8.2 Hz, <i>J</i><sub>m</sub> = 1.9 Hz), 7.43 (d, 1H, <i>J</i> = 8.0 Hz), 7.50 (d, 1H, <i>J</i><sub>m</sub> = 1.9 Hz), 7.56 (t, 1H, <i>J</i> = 8.1 Hz), 8.59 (s, 1H), 8.62 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 118.73, 120.09, 121.50, 125.83, 131.84, 133.76, 137.92, 144.29, 153.14, 157.88. LC-MS: <i>t</i><sub>R</sub> = 7.89 min; <i>m</i>/<i>z</i>: 240.9 (M + H)<sup>+</sup> calcd for C<sub>10</sub>H<sub>7</sub>Cl<sub>2</sub>N<sub>2</sub>O. HRMS: (M + H)<sup>+</sup> calcd for C<sub>10</sub>H<sub>7</sub>Cl<sub>2</sub>N<sub>2</sub>O, 240.9935; found, 240.9933.</div></div><div id="sec3_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2-Chloro-6-(3-acetamidophenyl-oxy)-pyrazine (<b>46</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (200 mg, 1.34 mmol) and 3-acetamidophenol (202 mg, 1.49 mmol). Crystallization from AcOEt e gave the title compound (350 mg). Yield: 99%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.06 (s, 3H), 6.90−6.95 (m, 1H), 7.76 (dd, 2H, <i>J</i><sub>m</sub> = 2.0 Hz, <i>J</i><sub>o</sub> = 7.6 Hz), 7.59 (s, 1H), 8.52 (s, 1H), 8.54 (s, 1H), 10.12 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 24.01, 111.39, 115.40, 116.02, 130.00, 133.66, 137.57, 140.82, 144.42, 152.57, 158.23, 168.55. LC-MS: <i>t</i><sub>R</sub> = 6.02 min; <i>m</i>/<i>z</i>: 264.0 (M + H)<sup>+</sup> calcd for C<sub>12</sub>H<sub>11</sub>ClN<sub>3</sub>O<sub>2</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>12</sub>H<sub>11</sub>ClN<sub>3</sub>O<sub>2</sub>, 264.0540; found, 264.0525.</div></div><div id="sec3_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2-Chloro-6-(4-acetamidophenyl-oxy)-pyrazine (<b>47</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (200 mg, 1.34 mmol) and 4-acetamidophenol (202 mg, 1.49 mmol). Crystallization from AcOEt afforded the title compound (327 mg). Yield: 92%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.12 (s, 3H), 7.25 (d, 2H, <i>J</i> = 8.9 Hz), 7.71 (d, 2H, <i>J</i> = 8.9 Hz), 8.55 (s, 1H), 8.57 (s, 1H), 10.10 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.89, 120.29, 121.38, 133.46, 136.96, 137.22, 144.37, 158.58, 168.22. LC-MS: <i>t</i><sub>R</sub> = 5.90 min; <i>m</i>/<i>z</i>: 264.0 (M + H)<sup>+</sup> calcd for C<sub>12</sub>H<sub>11</sub>ClN<sub>3</sub>O<sub>2</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>12</sub>H<sub>11</sub>ClN<sub>3</sub>O<sub>2</sub>, 264.0540; found, 264.0545.</div></div><div id="sec3_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 2-Chloro-6-(acetophenone-3-oxy)-pyrazine (<b>48</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (220 mg, 1.49 mmol) and 3-hydroxyacetophenone (200 mg, 1.47 mmol). Crystallization from AcOEt gave the title compound (370 mg). Yield: 96%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.61 (s, 3H), 7.57 (dd, 1H, <i>J</i><sub>m</sub> = 1.2 Hz, <i>J</i><sub>o</sub> = 9.0 Hz), 7.65 (t, 1H, <i>J</i> = 7.8 Hz), 7.82 (d, 1H, <i>J</i><sub>m</sub> = 2.0 Hz), 7.88 (dd, 1H, <i>J</i><sub>m</sub> = 1.3 Hz, <i>J</i><sub>o</sub> = 7.5 Hz), 8.55 (s, 1H), 8.61 (s, 1H). LC-MS: <i>t</i><sub>R</sub> = 6.52 min; <i>m</i>/<i>z</i>: 249.0 (M + H)<sup>+</sup> calcd for C<sub>12</sub>H<sub>9</sub>ClN<sub>2</sub>O<sub>2</sub> 248.0.</div></div><div id="sec3_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 2-Chloro-6-(acetophenone-4-oxy)-pyrazine (<b>49</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (220 mg, 1.49 mmol) and 4-hydroxyacetophenone (200 mg, 1.47 mmol). Crystallization from AcOEt furnished the title compound (365 mg). Yield: 99%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.61 (s, 3H), 7.42 (d, 2H, <i>J</i> = 8.7 Hz), 8.08 (d, 2H, <i>J</i> = 8.7 Hz), 8.59 (s, 1H), 8.63 (s, 1H). LC-MS: <i>t</i><sub>R</sub> = 6.52 min; <i>m</i>/<i>z</i>: 249.0 (M + H)<sup>+</sup> calcd for C<sub>12</sub>H<sub>9</sub>ClN<sub>2</sub>O<sub>2</sub>.</div></div><div id="sec3_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 2-Chloro-6-(6-acetamido-naphthyl-1-oxy)-pyrazine (<b>50</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (250 mg, 1.68 mmol) and 6-acetamido-1-naphthol (350 mg, 1.72 mmol). Crystallization from AcOEt produced the title compound (526 mg). Yield: 100%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.12 (s, 3H), 7.29 (d, 1H, <i>J</i> = 7.4 Hz), 7.53 (t, 1H, <i>J</i> = 7.9 Hz), 7.57−7.62 (m, 1H), 7.80 (d, 1H, <i>J</i> = 8.2 Hz), 7.85 (d, 1H, <i>J</i> = 9.1 Hz), 8.42 (d, 1H, <i>J</i> = 1.3 Hz), 8.53 (s, 1H), 8.67 (s, 1H), 10.23 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.89, 120.29, 121.38, 133.46, 136.96, 137.22, 144.37, 158.58, 168.22. LC-MS: <i>t</i><sub>R</sub> = 5.90 min; <i>m</i>/<i>z</i>: 264.0 (M + H)<sup>+</sup> calcd for C<sub>12</sub>H<sub>11</sub>ClN<sub>3</sub>O<sub>2</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>12</sub>H<sub>11</sub>ClN<sub>3</sub>O<sub>2</sub>, 264.0540; found, 264.0545.</div></div><div id="sec3_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 2-Chloro-6-(5-acetamido-naphthyl-1-oxy)-pyrazine (<b>51</b>)</h3><div class="NLM_p last">Method F was followed with 2,6-dichloropyrazine (200 mg, 1.34 mmol) and 5-acetamido-1-naphthol (270 mg, 1.49 mmol). Crystallization from AcOEt gave the title compound (379 mg). Yield: 90%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.27 (s, 3H), 7.54 (t, 1H, <i>J</i> = 8.0 Hz), 7.59 (d, 1H, <i>J</i> = 7.5 Hz), 7.68 (t, 1H, <i>J</i> = 8.0 Hz), 7.80 (d, 1H, <i>J</i> = 7.2 Hz), 7.83 (d, 1H, <i>J</i> = 6.4 Hz), 8.13 (d, 1H, <i>J</i> = 8.4 Hz), 8.59 (s, 1H), 8.78 (s, 1H), 10.10 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.47, 117.94, 118.14, 120.98, 122.31, 125.65, 126.51, 127.12, 129.19, 133.58, 134.22, 137.59, 144.42, 148.21, 158.81, 168.99. LC-MS: <i>t</i><sub>R</sub> = 6.30 min; <i>m</i>/<i>z</i>: 313.1 (M)<sup>+</sup> calcd for C<sub>16</sub>H<sub>12</sub>ClN<sub>3</sub>O<sub>2</sub>.</div></div><div id="sec3_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 2-(3,4,5-Trimethoxyphenylamino)-6-(7-coumarinyloxy)-pyrazine (<b>52</b>) (Method G)</h3><div class="NLM_p last">In a tube suitable for parallel synthesis, 2-chloro-6-(coumarin-1-yl-6-oxy)-pyrazine (200 mg, 0.72 mmol) was reacted with 3,4,5-trimethoxyaniline (158 mg, 0.86 mmol) in dry, degassed toluene (10 mL) in the presence of Pd(0)<sub>2</sub>·dba<sub>3</sub> (20 mg, 0.022 mmol, 3 mol %), 2-dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino)-biphenyl (16 mg, 0.044 mmol, 6% mol) and sodium <i>tert</i>-butoxide (138 mg, 1.44 mmol). This mixture was stirred at 90 °C for 20 h under a N<sub>2</sub> atmosphere. The reaction content was evaporated to dryness in vacuum, and the solid residue was retaken in hot AcOEt (2 × 10 mL). The solutions were filtered, pooled, washed with 0.1N HCl (10 mL) and water, dried (MgSO<sub>4</sub>), and evaporated again. The solid residue was purified by column chromatography (AcOEt:EtOH, 1:1) to give the title compound (102 mg). Yield: 34%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.31 (s, 6H), 3.39 (s, 3H), 6.47 (d, 1H, <i>J</i> = 9.6 Hz), 6.77 (s, 2H), 7.22 (dd, 1H, <i>J<sub>o</sub></i> = 8.5 Hz, <i>J</i><sub>m</sub> = 2.3 Hz), 7.34 (d, 1H, <i>J</i> = 2.2 Hz), 7.72 (d, 1H, <i>J</i> = 8.5 Hz), 7.84 (s, 1H), 8.03 (s, 1H), 8.10 (d, 1H, <i>J</i> = 9.62 Hz), 9.63 (s, 1H, NH). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.16, 60.04, 96.23, 108.23, 114.70, 115.49, 117.27, 121.24, 129.45, 129.66, 132.09, 143.89, 150.52, 152.67, 154.59, 156.51, 156.75, 159.74. LC-MS: <i>t</i><sub>R</sub> = 6.93 min; <i>m</i>/<i>z</i>: 422.1 (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>20</sub>N<sub>3</sub>O<sub>6</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>20</sub>N<sub>3</sub>O<sub>6</sub>, 422.1352; found, 422.1341.</div></div><div id="sec3_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 2-(3,4,5-Trimethoxyphenylamino)-6-(quinoline-4-oxy)-pyrazine (<b>53</b>)</h3><div class="NLM_p last">Using method G with 2-chloro-6-(quinolyl-4-oxy)-pyrazine (150 mg, 0.58 mmol) and 3,4,5-trimethoxyaniline (128 mg, 0.70 mmol), the title compound (48 mg) was obtained after crystallization from AcOEt. Yield: 20%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.22 (s, 6H), 3.49 (s, 3H), 6.67 (s, 2H), 7.16 (d, 1H, <i>J</i> = 5.0 Hz), 7.66 (t, 1H, <i>J</i> = 7.7 Hz), 7.84 (t, 1H), 8.02 (s, 1H), 8.08 (d, 1H, <i>J</i> = 8.1 Hz), 8.09 (s, 1H), 8.16 (d, 1H, <i>J</i> = 8.1 Hz), 8.80 (d, 1H, <i>J</i> = 5.0 Hz), 9.71 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.01, 59.98, 95.78, 110.29, 121.47, 121.63, 121.81, 126.91, 128.99, 130.28, 132.21, 135.94, 149.51, 150.67, 151.32, 152.58, 156.37, 157.59. LC-MS: <i>t</i><sub>R</sub> = 6.80 min; <i>m</i>/<i>z</i>: 406.7 (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>, 405.1563; found, 405.1564.</div></div><div id="sec3_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 2-(3,4,5-Trimethoxyphenylamino)-6-(quinoline-5-oxy)-pyrazine (<b>54</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(quinolyl-5-oxy)-pyrazine (150 mg, 0.58 mmol) and 3,4,5-trimethoxyaniline (128 mg, 0.70 mmol). Crystallization (AcOEt) afforded the title compound (77 mg). Yield: 33%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.18 (s, 6H), 3.47 (s, 3H), 6.57 (s, 2H), 7.43 (d, 1H, <i>J</i> = 7.5 Hz), 7.53−7.57 (m, 1H), 7.78 (t, 1H, <i>J</i> = 8.5 Hz), 7.93 (d, 1H, <i>J</i> = 8.3 Hz), 8.37 (d, 1H, <i>J</i> = 8.0 Hz), 7.94 (s, 1H), 7.99 (s, 1H), 8.40 (d, 1H, <i>J</i> = 8.3 Hz), 8.96 (dd, 1H, <i>J</i><sub>a</sub> = 1.5 Hz, <i>J</i><sub>b</sub> = 3.7 Hz), 9.56 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.12, 59.97, 95.56, 117.40, 120.93, 121.78, 122.04, 125.78, 128.72, 129.39, 130.08, 132.11, 136.08, 148.60, 149.19, 150.56, 151.17, 152.56, 157.89. LC-MS: <i>t</i><sub>R</sub> = 7.00 min; <i>m</i>/<i>z</i>: 405.1 (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>, 405.1563; found, 405.1561.</div></div><div id="sec3_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 2-(3,4,5-Trimethoxyphenylamino)-6-(quinoline-6-oxy)-pyrazine (<b>55</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(quinolyl-6-oxy)-pyrazine (150 mg, 0.58 mmol) and 3,4,5-trimethoxyaniline (128 mg, 0.70 mmol). Crystallization (AcOEt) gave the title compound (149 mg). Yield: 64%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.06 (s, 6H), 3.45 (s, 3H), 6.68 (s, 2H), 7.50−7.55 (m, 1H), 7.63 (d, 1H, <i>J</i> = 9.1 Hz), 7.80 (s, 1H), 7.87 (s, 1H), 8.00 (s, 1H), 8.08 (d, 1H, <i>J</i> = 9.1 Hz), 8.33 (d, 1H, <i>J</i> = 8.2 Hz), 8.89 (d, 1H, <i>J</i> = 2.5 Hz), 9.60 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 54.84, 59.97, 95.87, 116.89, 121.19, 121.88, 124.52, 128.62, 128.83, 130.72, 132.23, 135.36, 136.17, 145.26, 149.89, 150.57, 151.60, 152.58, 157.24. LC-MS: <i>t</i><sub>R</sub> = 6.88 min; <i>m</i>/<i>z</i>: 405.1 (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>, 405.1563; found, 405.1571.</div></div><div id="sec3_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 2-(3,4,5-Trimethoxyphenylamino)-6-(isoquinoline-5-oxy)-pyrazine (<b>56</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(isoquinolyl-5-oxy)-pyrazine (150 mg, 0.58 mmol) and 3,4,5-trimethoxyaniline (128 mg, 0.70 mmol). Crystallization (AcOEt) and purification by column chromatography (AcOEt) afforded the title compound (67 mg). Yield: 29%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.20 (s, 6H), 3.48 (s, 3H), 6.55 (s, 2H), 7.62 (d, 1H, <i>J</i> = 7.5 Hz), 7.71 (t, 1H, <i>J</i> = 7.9 Hz), 7.80 (d, 1H, <i>J</i> = 5.8 Hz), 7.95 (s, 1H), 7.99 (s, 1H), 8.03 (d, 1H, <i>J</i> = 8.1 Hz), 8.52 (d, 1H, <i>J</i> = 5.8 Hz), 9.41 (s, 1H), 9.55 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.27, 59.99, 95.91, 114.19, 120.90, 121.33, 124.41, 127.71, 128.77, 129.24, 129.31, 132.35, 136.03, 143.38, 148.42, 150.55, 152.42, 152.60, 157.78. LC-MS: <i>t</i><sub>R</sub> = 6.42 min; <i>m</i>/<i>z</i>: 405.1 (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>, 405.1563; found, 405.1579.</div></div><div id="sec3_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 2-(3,4,5-Trimethoxyphenylamino)-6-(5-tetral-1-one-oxy)-pyrazine (<b>57</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(tetralon-1-yl-5-oxy)-pyrazine (200 mg, 0.73 mmol) and 3,4,5-trimethoxyaniline (160 mg, 0.87 mmol). Purification by column chromatography (AcOEt) afforded the title compound (193 mg). Yield: 63%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.99−2.02 (m, 2H), 2.60 (t, 2H, <i>J</i> = 5.9 Hz), 2.77 (t, 2H, <i>J</i> = 5.9 Hz), 3.41 (s, 6H), 3.55 (s, 3H), 6.69 (s, 2H), 7.40−7.44 (m, 2H), 7.88 (d, 1H, <i>J</i> = 6.8 Hz), 7.81 (s, 1H), 7.95 (s, 1H), 9.52 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 21.95, 22.97, 55.52, 60.06, 96.28, 120.55, 123.11, 127.20, 128.06, 136.67, 152.72, 197.00. LC-MS: <i>t</i><sub>R</sub> = 7.49 min; <i>m</i>/<i>z</i>: 422.1 (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub>, 422.1716; found, 422.1717.</div></div><div id="sec3_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 2-(3,4,5-Trimethoxyphenylamino)-6-(6-tetral-1-one-oxy)-pyrazine (<b>58</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(tetralon-1-yl-6-oxy)-pyrazine (200 mg, 0.73 mmol) and 3,4,5-trimethoxyaniline (160 mg, 0.87 mmol). Purification by column chromatography (AcOEt) gave the title compound (182 mg). Yield: 59%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.02−2.09 (m, 2H), 2.62 (t, 2H, <i>J</i> = 6.8 Hz), 2.92 (t, 2H, <i>J</i> = 5.8 Hz), 3.40 (s, 6H), 3.55 (s, 3H), 6.79 (s, 2H), 7.13 (dd, 1H, <i>J</i><sub>o</sub> = 8.5 Hz, <i>J</i><sub>m</sub> = 2.4 Hz), 7.18 (d, 1H, <i>J</i> = 2.2 Hz), 7.82 (s, 1H), 7.92 (d, 1H, <i>J</i> = 8.5 Hz), 8.02 (s, 1H), 9.63 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 22.72, 28.90, 55.15, 59.71, 60.04, 96.06, 118.66, 119.71, 121.39, 128.62, 129.42, 132.32, 136.12, 147.04, 150.57, 152.66, 156.43, 158.01, 196.28. LC: <i>t</i><sub>R</sub> = 7.49 min; <i>m</i>/<i>z</i>: 422.2 (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>24</sub>N<sub>3</sub>O<sub>5</sub>.</div></div><div id="sec3_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 2-(3,4,5-Trimethoxyphenylamino)-6-(indanone-4-oxy)-pyrazine (<b>59</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(indanone-4-oxy)-pyrazine (200 mg, 0.77 mmol) and 3,4,5-trimethoxyaniline (169 mg, 0.92 mmol). Purification by column chromatography (AcOEt) produced the title compound (71 mg). Yield: 23%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.69 (t, 2H, <i>J</i> = 3.7 Hz), 2.98 (t, 2H, <i>J</i> = 5.2 Hz), 3.43 (s, 6H), 3.59 (s, 3H), 6.75 (s, 2H), 7.56−7.62 (m, 3H), 7.90 (s, 1H), 8.04 (s, 1H), 9.62 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 22.68, 35.68, 55.45, 60.04, 96.06, 119.46, 120.72, 126.71, 128.54, 129.16, 132.51, 136.11, 139.04, 146.34, 150.51, 151.32, 152.70, 156.89, 205.47. LC: <i>t</i><sub>R</sub> = 7.10 min; <i>m</i>/<i>z</i>: 408.1 (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub>, 408.1559; found, 408.1552.</div></div><div id="sec3_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 2-(3,4,5-Trimethoxyphenylamino)-6-(indanone-5-oxy)-pyrazine (<b>60</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(indanone-5-oxy)-pyrazine (200 mg, 0.77 mmol) and 3,4,5-trimethoxyaniline (169 mg, 0.92 mmol). Purification by column chromatography (AcOEt) afforded the title compound (61 mg). Yield: 20%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.68 (t, 2H, <i>J</i> = 5.6 Hz), 3.08 (t, 2H, <i>J</i> = 5.0 Hz), 3.39 (s, 6H), 3.55 (s, 3H), 6.77 (s, 2H), 7.21 (dd, 1H, <i>J</i><sub>m</sub> = 1.9 Hz, <i>J</i><sub>o</sub> = 8.3 Hz), 7.40 (s, 1H), 7.68 (d, 1H, <i>J</i> = 8.3 Hz), 7.84 (s, 1H), 8.02 (s, 1H), 9.62 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 25.36, 36.04, 55.15, 60.05, 96.21, 118.03, 120.08, 121.40, 124.56, 129.45, 132.44, 132.96, 136.09, 150.61, 152.68, 156.57, 157.62, 159.52, 204.62. LC-MS: <i>t</i><sub>R</sub> = 7.11 min; <i>m</i>/<i>z</i>: 408.1 [(M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub>, 408.1559; found, 408.1561.</div></div><div id="sec3_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 2-(3,4,5-Trimethoxyphenylamino)-6-(indanone-6-oxy)-pyrazine (<b>61</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(indanone-6-oxy)-pyrazine (200 mg, 0.77 mmol) and 3,4,5-trimethoxyaniline (169 mg, 0.92 mmol). Purification by column chromatography (AcOEt) furnished the title compound (30 mg). Yield: 10%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.73 (t, 2H, <i>J</i> = 5.4 Hz), 3.13 (t, 2H, <i>J</i> = 5.8 Hz), 3.37 (s, 6H), 3.54 (s, 3H), 6.72 (s, 2H), 7.37 (d, 1H, <i>J</i> = 2.2 Hz), 7.52 (dd, 1H, <i>J</i><sub>m</sub> = 2.3 Hz, <i>J</i><sub>o</sub> = 7.2 Hz), 7.64 (d, 1H, <i>J</i> = 8.3 Hz), 7.81 (s, 1H), 7.98 (s, 1H), 9.57 (s, 1H). LC: <i>t</i><sub>R</sub> = 6.94 min; <i>m</i>/<i>z</i>: 408.1 (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub>.</div></div><div id="sec3_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 2-(3,4,5-Trimethoxyphenylamino)-6-[(2-phenyl)-phenyl-oxy]-pyrazine (<b>62</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-[(2-phenyl)-phenyl-oxy]-pyrazine (110 mg, 0.39 mmol) and 3,4,5-trimethoxyaniline (84 mg, 0.46 mmol). Purification by column chromatography (AcOEt) afforded the title compound (101 mg). Yield: 60%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.41 (s, 6H), 3.55 (s, 3H), 6.79 (s, 2H), 7.22−7.49 (m, 9H), 7.66 (s, 1H), 7.88 (s, 1H), 9.51 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.33, 60.03, 95.51, 121.09, 122.25, 125.32, 127.35, 127.99, 128.29, 128.57, 128.91, 130.83, 132.05, 133.73, 136.40, 137.20, 150.59, 152.71, 157.61. LC-MS: <i>t</i><sub>R</sub> = 8.25 min; <i>m</i>/<i>z</i>: 430.1 (M + H)<sup>+</sup> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub>, 430.1767; found, 430.1758.</div></div><div id="sec3_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 2-(3,4,5-Trimethoxyphenylamino)-6-(2-fluorophenyl-oxy)-pyrazine (<b>63</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(2-fluorophenyloxy)-pyrazine (200 mg, 0.89 mmol) and 3,4,5-trimethoxyaniline (196 mg, 1.07 mmol). Purification by column chromatography (AcOEt:cyclohexane, 1:1) afforded the title compound (234 mg). Yield: 71%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.42 (s, 6H), 3.54 (s, 3H), 6.69 (s, 2H), 7.24−7.41 (m, 4H), 7.83 (s, 1H), 7.96 (s, 1H), 9.57 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.73, 60.04, 95.77, 116.92, 120.15, 123.79, 125.26, 126.52, 128.47, 132.28, 136.13, 140.27, 150.39, 152.71, 154.80, 156.98, 170.32. LC-MS: <i>t</i><sub>R</sub> = 7.50 min; <i>m</i>/<i>z</i>: 372.1 (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>3</sub>O<sub>4</sub>, 372.1360; found, 372.1363.</div></div><div id="sec3_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-fluorophenyl-oxy)-pyrazine (<b>64</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(3-fluorophenyloxy)-pyrazine (200 mg, 0.89 mmol) and 3,4,5-trimethoxyaniline (196 mg, 1.07 mmol). Purification by column chromatography (AcOEt:cyclohexane, 1:1) gave the title compound (200 mg). Yield: 61%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.44 (s, 6H), 3.55 (s, 3H), 6.77 (s, 2H), 7.02−7.09 (m, 2H), 7.16 (d, 1H, <i>J</i><sub>F</sub> = 8.8 Hz), 7.43 (q, 1H, <i>J</i> = 8.5 Hz), 7.78 (s, 1H), 7.98 (s, 1H), 9.61 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.23, 60.04, 95.80, 108.46, 111.40, 116.74, 121.14, 128.99, 130.94, 132.18, 136.21, 150.49, 152.68, 154.98, 156.73, 161.60, 163.55, 170.32. LC-MS: <i>t</i><sub>R</sub> = 7.82 min; <i>m</i>/<i>z</i>: 372.1 (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>3</sub>O<sub>4</sub>, 372.1360; found, 372.1357.</div></div><div id="sec3_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-chlorophenyl-oxy)-pyrazine (<b>65</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(3-chlorophenyloxy)-pyrazine (200 mg, 0.83 mmol) and 3,4,5-trimethoxyaniline (183 mg, 1.00 mmol). Purification by column chromatography (AcOEt:cyclohexane, 1:1) produced the title compound (165 mg). Yield: 43%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.43 (s, 6H), 3.54 (s, 3H), 6.76 (s, 2H), 7.18 (d, 1H, <i>J</i> = 6.5 Hz), 7.28 (d, 1H, <i>J</i> = 6.7 Hz), 7.36 (s, 1H), 7.43 (t, 1H, <i>J</i> = 8.1 Hz), 7.79 (s, 1H), 7.98 (s, 1H), 9.62 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 55.32, 60.04, 95.75, 119.55, 120.80, 121.27, 124.58, 128.98, 131.14, 132.17, 133.71, 136.20, 138.57, 150.47, 152.68, 153.24, 154.69, 156.67, 170.32. LC-MS: <i>t</i><sub>R</sub> = 8.19 min; <i>m</i>/<i>z</i>: 388.1 (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>4</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>4</sub>, 388.1064; found, 388.1051.</div></div><div id="sec3_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-acetamidophenyl-oxy)-pyrazine (<b>66</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(3-acetamidophenyl-oxy)-pyrazine (150 mg, 0.57 mmol) and 3,4,5-trimethoxyaniline (125 mg, 0.68 mmol). Crystallization (AcOEt) gave the title compound (81 mg). Yield: 35%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.03 (s, 3H), 3.44 (s, 6H), 3.56 (s, 3H), 6.80 (s, 2H), 6.82−6.87 (m, 1H), 7.31−7.49 (m, 2H), 7.50 (s, 1H), 7.76 (s, 1H), 7.97 (s, 1H), 9.55 (s, 1H), 10.04 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.98, 55.30, 60.03, 95.75, 110.84, 114.83, 121.21, 128.57, 129.75, 132.14, 136.27, 140.69, 150.60, 152.69, 154.20, 157.21, 168.47. LC-MS: <i>t</i><sub>R</sub> = 6.86 min; <i>m</i>/<i>z</i>: 411.2 (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>5</sub>, 411.1668; found, 411.1677.</div></div><div id="sec3_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-acetamidophenyl-oxy)-pyrazine (<b>67</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(4-acetamidophenyl-oxy)-pyrazine (150 mg, 0.57 mmol) and 3,4,5-trimethoxyaniline (125 mg, 0.68 mmol). Crystallization (AcOEt) furnished the title compound (87 mg). Yield: 37%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.07 (s, 3H), 3.43 (s, 6H), 3.55 (s, 3H), 6.77 (s, 2H), 7.13 (d, 2H, <i>J</i> = 8.9 Hz), 7.60 (d, 2H, <i>J</i> = 8.9 Hz), 7.73 (s, 1H), 7.93 (s, 1H), 9.51 (s, 1H), 9.98 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.87, 55.29, 60.04, 95.71, 120.14, 120.92, 128.01, 132.13, 136.35, 148.77, 150.49, 152.70, 157.62, 168.11. LC-MS: <i>t</i><sub>R</sub> = 6.69 min; <i>m</i>/<i>z</i>: 411.2 (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>5</sub>, 411.1668; found, 411.1654.</div></div><div id="sec3_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-methcarbonylphenyl-oxy)-pyrazine (<b>68</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(acetophenone-3-oxy)-pyrazine (200 mg, 0.80 mmol) and 3,4,5-trimethoxyaniline (176 mg, 0.96 mmol). Purification by column chromatography (AcOEt:cyclohexane, 9:1) gave the title compound (85 mg). Yield: 27%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.61 (s, 3H), 3.39 (s, 6H), 3.54 (s, 3H), 6.74 (s, 2H), 7.49 (dd, 1H, <i>J</i><sub>m</sub> = 2.3 Hz, <i>J</i><sub>o</sub> = 9.3 Hz), 7.59 (t, 1H, <i>J</i> = 8.0 Hz), 7.73 (d, 1H, <i>J</i><sub>m</sub> = 2.0 Hz), 7.81 (s, 1H), 7.82 (d, 1H, <i>J</i> = 6.8 Hz), 7.99 (s, 1H), 9.57 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 26.77, 55.32, 60.03, 96.13, 119.90, 121.13, 124.40, 128.74, 130.20, 132.38, 136.13, 138.50, 145.11, 150.48, 152.68, 153.27, 154.02, 156.99, 197.24. LC-MS: <i>t</i><sub>R</sub> = 7.14 min; <i>m</i>/<i>z</i>: 396.2 (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub>, 396.1559; found, 396.1554.</div></div><div id="sec3_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-methcarbonylphenyl-oxy)-pyrazine (<b>69</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(acetophenone-4-oxy)-pyrazine (150 mg, 0.60 mmol) and 3,4,5-trimethoxyaniline (148 mg, 0.72 mmol). Purification by column chromatography (AcOEt:cyclohexane, 9:1) afforded the title compound (85 mg). Yield: 34%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.56 (s, 3H), 3.43 (s, 6H), 3.59 (s, 3H), 6.82 (s, 2H), 7.37 (d, 2H, <i>J</i> = 8.7 Hz), 7.89 (s, 1H), 8.07 (d, 2H, <i>J</i> = 6.7 Hz), 8.08 (s, 1H), 9.68 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 26.57, 55.33, 60.02, 95.58, 120.24, 121.36, 129.41, 130.24, 132.30, 133.08, 136.12, 150.55, 152.67, 156.50, 157.95, 196.62. LC-MS: <i>t</i><sub>R</sub> = 7.21 min; <i>m</i>/<i>z</i>: 396.2 (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub>, 396.1559; found, 396.1567.</div></div><div id="sec3_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 2-(3,4,5-Trimethoxyphenylamino)-6-(5-methcarbonylaminonaphthyl-oxy)-pyrazine (<b>70</b>)</h3><div class="NLM_p last">Method G was followed with 2-chloro-6-(5-acetamidonaphthyl-oxy)-pyrazine (200 mg, 0.64 mmol) and 3,4,5-trimethoxyaniline (140 mg, 0.76 mmol). Purification by column chromatography (AcOEt) produced the title compound (72 mg). Yield: 24%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.23 (s, 3H), 3.32 (s, 6H), 3.49 (s, 3H), 6.60 (s, 2H), 7.35 (d, 1H, <i>J</i> = 7.4 Hz), 7.52 (t, 1H, <i>J</i> = 7.9 Hz), 7.56 (t, 1H, <i>J</i> = 7.9 Hz), 7.75 (d, 1H, <i>J</i> = 7.3 Hz), 7.84 (d, 1H, <i>J</i> = 8.4 Hz), 7.93 (s, 1H), 7.97 (s, 1H), 7.99 (d, 1H, <i>J</i> = 7.7 Hz), 9.50 (s, 1H), 9.97 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.45, 55.11, 59.96, 95.56, 117.23, 118.39, 119.74, 120.35, 120.93, 122.37, 125.70, 126.16, 127.61, 128.38, 129.24, 132.03, 134.05, 136.17, 145.13, 149.70, 150.64, 152.59, 153.26, 158.19, 168.99. LC-MS: <i>t</i><sub>R</sub> = 7.01 min; <i>m</i>/<i>z</i>: 461.2 (M + H)<sup>+</sup> calcd for C<sub>25</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>25</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>, 461.1825; found, 461.1839.</div></div><div id="sec3_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 2-(3,4,5-Trimethoxyphenylamino)-6-(3-hydroxyiminoeth-2-yl-phenoxy)-pyrazine (<b>71</b>) (Method H)</h3><div class="NLM_p last">2-(3,4,5-Trimethoxyphenylamino)-6-(acetophenone-3-oxy)-pyrazine (90 mg, 0.22 mmol) and hydrazine hydrate solution 50% (40 µL, 0.96 mmol) were refluxed for 1.5 h in EtOH (5 mL). The reaction mixture was evaporated to dryness. Purification by column chromatography (AcOEt:EtOH, 9:1) furnished the title compound (37 mg). Yield: 41%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.61 (s, 3H), 3.39 (s, 6H), 3.54 (s, 3H), 7.18−7.21 (m, 1H), 7.43−7.50 (m, 3H), 7.79 (s, 1H), 7.97 (s, 1H), 9.55 (s, 1H), 11.29 (s, 1H). LC-MS: <i>t</i><sub>R</sub> = 7.29 min; <i>m</i>/<i>z</i>: 410.1(M)<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>4</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>5</sub>, 411.1668; found, 411.1678.</div></div><div id="sec3_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-hydroxyiminoeth-2-yl-phenoxy)-pyrazine (<b>72</b>)</h3><div class="NLM_p last">Method H was followed with 2-(3,4,5-trimethoxyphenylamino)-6-(acetophenone-4-oxy)-pyrazine (90 mg, 0.22 mmol) and hydrazine hydrate solution 50% (40 µL, 0.96 mmol). Purification by column chromatography (AcOEt:EtOH, 9:1) afforded the title compound (30 mg). Yield: 33%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.56 (s, 3H), 3.44 (s, 6H), 3.60 (s, 3H), 6.83 (s, 2H), 7.26 (d, 2H, <i>J</i> = 8.7 Hz), 7.74 (d, 2H, <i>J</i> = 8.7 Hz), 7.84 (s, 1H), 8.02 (s, 1H), 9.63 (s, 1H), 11.25 (s, 1H). LC-MS: <i>t</i><sub>R</sub> = 7.35 min; <i>m</i>/<i>z</i>: 410.1(M)<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>4</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>4</sub>O<sub>5</sub>, 411.1668; found, 411.1636.</div></div><div id="sec3_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 2-(3,4,5-Trimethoxyphenylamino)-6-(indanone-oxime-4-oxy)-pyrazine (<b>73</b>)</h3><div class="NLM_p last">Method H was followed (reaction time: 5 h) with 2-(3,4,5-trimethoxyphenylamino)-6-(indanone-4-oxy)-pyrazine (70 mg, 0.17 mmol) and hydrazine hydrate solution (32 µL, 0.51 mmol). The title compound was obtained (30 mg) by crystallization (AcOEt). Yield: 42%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.78 (m, 2H), 3.36 (m, 2H), 3.38 (s, 6H), 3.53 (s, 3H), 6.72 (s, 2H), 7.18 (d, 1H, <i>J</i> = 7.6 Hz), 7.33 (t, 1H, <i>J</i> = 7.7 Hz), 7.44 (d, 1H, <i>J</i> = 7.3 Hz), 7.80 (s, 1H), 7.96 (s, 1H), 9.57 (s, 1H), 11.02 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 24.55, 25.42, 55.43, 60.03, 95.87, 117.18, 119.46, 120.75, 121.77, 126.71, 128.22, 128.35, 128.78, 129.15, 132.31, 136.10, 138.94, 139.31, 150.59, 152.71, 157.08, 160.49. LC-MS: <i>t</i><sub>R</sub> = 7.24 min; <i>m</i>/<i>z</i>: 423.2 (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>4</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>4</sub>O<sub>5</sub>, 423.1668; found, 423.1654.</div></div><div id="sec3_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 2-(3,4,5-Trimethoxyphenylamino)-6-(tetralonyl-1-oxime-5-oxy)-pyrazine (<b>74</b>)</h3><div class="NLM_p last">Method H was followed (reaction time: 4.5 h) with 2-(3,4,5-trimethoxy phenylamino)-6-(tetralon-1-yl-5-oxy)-pyrazine (100 mg, 0.24 mmol) and hydrazine hydrate solution (44 µL, 0.70 mmol). The title compound was obtained (55 mg) by crystallization (AcOEt). Yield: 53%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.69 (t, 2H, <i>J</i> = 5.9 Hz), 2.64−2.65 (m, 4H), 3.40 (s, 6H), 3.53 (s, 3H), 6.71 (s, 2H), 7.13 (d, 1H, <i>J</i> = 7.9 Hz), 7.25 (t, 2H, <i>J</i> = 7.9 Hz), 7.76 (d, 1H, <i>J</i> = 5.2 Hz), 7.77 (s, 1H), 7.93 (s, 1H), 9.53 (s, 1H), 11.27 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 20.29, 22.82, 55.54, 60.04, 95.92, 120.21, 120.53, 121.36, 126.70, 127.76, 132.33, 150.55, 151.00, 152.08, 152.72, 157.64, 196.90. LC-MS: <i>t</i><sub>R</sub> = 7.60 min; <i>m</i>/<i>z</i>: 437.2 (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>, 437.1825; found, 437.1812.</div></div><div id="sec3_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 2-(3,4,5-Trimethoxyphenylamino)-6-(tetralonyl-1-oxime-6-oxy)-pyrazine (<b>75</b>)</h3><div class="NLM_p last">Method H was followed (reaction time: 4.5 h) with 2-(3,4,5-trimethoxy phenylamino)-6-(tetralon-1-yl-6-oxy)-pyrazine (100 mg, 0.24 mmol) and hydrazine hydrate solution (44 µL, 0.70 mmol). Crystallization (AcOEt) afforded the title compound (32 mg). Yield: 30%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.75 (t, 2H, <i>J</i> = 5.2 Hz), 2.61−2.68 (m, 4H), 3.40 (s, 6H), 3.54 (s, 3H), 6.79 (s, 2H), 7.03−7.18 (m, 2H), 7.78 (s, 1H), 7.87 (d, 1H, <i>J</i> = 8.4 Hz), 7.96 (s, 1H), 9.60 (s, 1H), 11.10 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 20.93, 22.78, 28.91, 55.22, 60.04, 95.92, 118.72, 120.02, 121.17, 124.89, 127.66, 128.57, 132.37, 136.27, 150.58, 151.89, 152.69, 157.10, 196.27. LC-MS: <i>t</i><sub>R</sub> = 7.72 min; <i>m</i>/<i>z</i>: 437.2 (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>, 437.1825; found, 437.1822.</div></div><div id="sec3_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 2-(3,4,5-Trimethoxyphenylamino)-6-(4-methaminocarbonyl-naphthyloxy)-pyrazine (<b>76</b>)</h3><div class="NLM_p last">Using method E with <i>N</i>-(4-hydroxynaphthalen-1-yl)acetamide (200 mg, 0.99 mmol), the title compound was obtained (31 mg). Yield: 6.7%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.21 (s, 3H), 3.20 (s, 9H), 3.48 (s, 3H), 6.61 (s, 2H), 7.31 (d, 1H, <i>J</i> = 8.2 Hz), 7.59 (t, 2H, <i>J</i> = 7.6 Hz), 7.70 (d, 1H, <i>J</i> = 8.3 Hz), 7.91 (s, 1H), 7.96−7.99 (m, 2H), 8.13 (d, 1H, <i>J</i> = 7.8 Hz), 9.49 (s, 1H), 9.93 (s, 1H). <sup>13</sup>C NMR (62.9 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.44, 55.10, 59.95, 95.38, 116.77, 120.89, 121.48, 121.61, 123.18, 126.38, 126.53, 127.11, 128.23, 128.71, 130.90, 131.98, 136.18, 146.44, 150.64, 152.59, 158.26, 168.93. LC-MS: <i>t</i><sub>R</sub> = 7.29 min; <i>m</i>/<i>z</i>: 461.1 (M + H)<sup>+</sup> calcd for C<sub>25</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>25</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>, 461.1825; found, 461.1811.</div></div><div id="sec3_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 2[(3-Oxazol-5-yl)phenylamino]-6-(5-methaminocarbonylnaphthyl-oxy)pyrazine (<b>77</b>)</h3><div class="NLM_p last">Using method D (conventional heating, reaction time: 20 h) with 2-chloro-6-(5-acetamidonapht-1-yloxy)-pyrazine (150 mg, 0.48 mmol) and 3-(1,3-oxazol-5-yl-aniline) (96 mg, 0.60 mmol), the title compound was obtained (71 mg). Yield: 34%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.22 (s, 3H), 6.95 (t, 1H, <i>J</i> = 7.9 Hz), 7.06 (d, 1H, <i>J</i> = 8.5 Hz), 7.15 (d, 1H, <i>J</i> = 7.6 Hz), 7.44−7.46 (m, 2H), 7.49−7.52 (m, 2H), 7.57 (d, 1H, <i>J</i> = 7.6 Hz), 7.74 (d, 1H, <i>J</i> = 6.6 Hz), 7.77 (d, 1H, <i>J</i> = 8.2 Hz), 7.94 (s, 1H), 7.96 (s, 1H), 8.02 (d, 1H, <i>J</i> = 8.4 Hz), 8.36 (s, 1H), 9.68 (bs, 1H), 9.99 (bs, 1H). <sup>13</sup>C NMR (125.8 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.44, 113.35, 117.19, 117.82, 117.99, 118.40, 120.07, 120.86, 121.74, 122.02, 125.49, 126.10, 127.53, 127.61, 127.69, 129.22, 134.08, 140.57, 149.18, 149.98, 150.28, 151.61, 154.70, 158.28, 168.90. LC: <i>t</i><sub>R</sub> = 7.20 min; <i>m</i>/<i>z</i>: 438.1 (M + H)<sup>+</sup> calcd for C<sub>25</sub>H<sub>20</sub>N<sub>5</sub>O<sub>3</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>25</sub>H<sub>20</sub>N<sub>5</sub>O<sub>3</sub>, 438.1560; found, 438.1564.</div></div><div id="sec3_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 2-(3-oxo-1,3-Dihydroisobenzofuran-5-ylamino)-6-(5-methaminocarbonylnaphthyl-oxy) pyrazine (<b>78</b>)</h3><div class="NLM_p last">Using method D with 2-chloro-6-(5-acetamidonaphthyl-oxy)-pyrazine (150 mg, 0.48 mmol) and 6-amino-1,3-dihydroisobenzofuran-1-one (89 mg, 0.60 mmol), the title compound was obtained (8 mg). Yield: 4%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.21 (s, 3H), 5.24 (s, 2H), 7.17 (d, 1H, <i>J</i> = 8.5 Hz), 7.45−7.51 (m, 3H), 7.63 (d, 1H, <i>J</i> = 8.2 Hz), 7.68−7.75 (m, 3H), 7.92 (s, 1H), 7.98 (s, 1H), 8.05 (d, 1H, <i>J</i> = 8.7 Hz), 9.92 (bs, 1H), 10.00 (bs, 1H). LC-MS: <i>t</i><sub>R</sub> = 6.72 min; <i>m</i>/<i>z</i> 427.1 (M + H)<sup>+</sup> calcd for C<sub>24</sub>H<sub>18</sub>N<sub>4</sub>O<sub>4</sub>.</div></div><div id="sec3_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> 2[(3-Oxazol-5-yl)phenylamino]-6-(4-methaminocarbonylnaphthyl-oxy)pyrazine (<b>79</b>)</h3><div class="NLM_p last">Using method D with 2-chloro-6-(4-acetamidonaphthalen-1-yloxy)pyrazine (150 mg, 0.48 mmol) and 3-(1,3-oxazol-5-yl-aniline) (115 mg, 0.71 mmol), the title compound was obtained (97 mg). Yield: 46%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.22 (s, 3H), 6.95 (t, 1H, <i>J</i> = 7.9 Hz), 7.10 (d, 1H, <i>J</i> = 8.2 Hz), 7.14 (d, 1H, <i>J</i> = 7.7 Hz), 7.41 (d, 1H, <i>J</i> = 8.2 Hz), 7.44 (bs, 2H), 7.54 (t, 1H, <i>J</i> = 7.5 Hz), 7.60 (t, 1H, <i>J</i> = 7.4 Hz), 7.70 (d, 1H, <i>J</i> = 8.1 Hz), 7.91 (d, 1H, <i>J</i> = 8.5 Hz), 7.95 (bs, 2H), 8.16 (d, 1H, <i>J</i> = 8.4 Hz), 8.37 (s, 1H), 9.70 (bs, 1H), 9.99 (bs, 1H). <sup>13</sup>C NMR (125.8 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 23.43, 113.25, 117.10, 117.70, 117.81, 120.71, 121.66, 121.77, 123.32, 126.27, 126.53, 127.31, 127.45, 127.53, 128.92, 129.39, 131.23, 140.63, 146.10, 149.99, 150.27. LC-MS: <i>t</i><sub>R</sub> = 7.29 min; <i>m</i>/<i>z</i>: 438.1 (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>5</sub>O<sub>3</sub>. HRMS: (M + H)<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>5</sub>O<sub>3</sub>, 438.1566; found, 438.1565.</div></div><div id="sec3_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> <sup>V600E</sup>BRAF Kinase Assay</h3><div class="NLM_p last">Full-length rabbit MEK1 protein was expressed with a GST tag at the N-terminus and a C-terminal histidine tag in <i>Escherichia coli</i> JM109 bacteria and purified by nickel-agarose affinity chromatography. <sup>V600E</sup>BRAF was generated by infection of SF9 insect cells cultured in SF-900 II medium (Invitrogen, Paisley, Scotland) with a baculovirus containing full-length human BRAF with an N-terminal histidine tag. Assay buffer was 20 mM MOPS, pH 7.2 containing 5 mM EGTA, 10 mM MgCl<sub>2</sub>, 0.1% β-ME and 25 mM β-glycerophosphate. All incubations were at room temperature with shaking. One µg GST-MEK1, 0.07 µL of insect cell <sup>V600E</sup>BRAF lysate, and 0.5µL of inhibitor at the required concentrations (0.001 to 100 µM final concentration) were added to the wells of a glutathione-coated plate and the plate preincubated for 10 min. ATP in assay buffer (10 µL), to give a final concentration of 100 µM, was added to each well and the plates incubated for 45 min. The plates were then washed 3× with 200 µL of 0.1% Tween 20/water. Primary antibody (rabbit antiphospho MEK1/2 diluted 1/2000, Cell Signaling Technologies, Hitchin, UK) and Eu-labeled antirabbit secondary antibody (diluted 1/1000, Perkin-Elmer, Turku, Finland) were preincubated for 30 min and 50 µL added to the washed plates, which were incubated for a further hour. The plates were washed as before, and 100 µL DELFIA enhancement solution (Perkin-Elmer, Turku, Finland) added. The plates were sealed and incubated for 30 min and europium counts measured on a Victor 2 reader (Perkin-Elmer, Turku, Finland).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="note1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106"><a href="/doi/suppl/10.1021/jm070776b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Tables of purity and HPLC traces for final compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm070776b/suppl_file/jm070776b-file013.pdf">jm070776b-file013.pdf (18.52 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm070776b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline J. Springer</span> - <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ff9c9e8d909396919ad18c8f8d9691989a8dbf969c8dd19e9cd18a94"><span class="__cf_email__" data-cfemail="a1c2c0d3cecdc8cfc48fd2d1d3c8cfc6c4d3e1c8c2d38fc0c28fd4ca">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ion Niculescu-Duvaz</span> - <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Esteban Roman</span> - <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven R. Whittaker</span> - <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Friedlos</span> - <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruth Kirk</span> - <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian J. Scanlon</span> - <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence C. Davies</span> - <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Niculescu-Duvaz</span> - <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Marais</span> - <span class="hlFld-Affiliation affiliation">The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i105">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work is supported by Cancer Research UK (refs: C309/A2187 and C107/A3096), the Wellcome Trust, and The Institute of Cancer Research. We thank Professor Paul Workman for helpful discussions and support and John Harris, Biofocus, for useful discussions. We also thank Meirion Richards for his help in evaluating the purity of the compounds and the accurate mass.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87346" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87346" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wellbrock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasarides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, R.</span><span> </span><span class="NLM_article-title">The RAF proteins take center stage</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">875</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm070776b&amp;key=10.1038%2Fnrm1498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm070776b&amp;key=15520807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm070776b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFemsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=875-885&author=C.+Wellbrockauthor=M.+Karasaridesauthor=R.+Marais&title=The+RAF+proteins+take+center+stage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The RAF proteins take center stage</span></div><div class="casAuthors">Wellbrock, Claudia; Karasarides, Maria; Marais, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">875-885</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since their discovery over 20 years ago, the RAF proteins have been intensely studied.  For most of that time, the focus of the field has been the C-RAF isoform and its role as an effector of the RAS proteins.  However, a report that implicates B-RAF in human cancer has highlighted the importance of all members of this protein kinase family and recent studies have uncovered intriguing new data relating to their complex regulation and biol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvN4GggcdfU7Vg90H21EOLACvtfcHk0ljbArmsVPGN8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFemsLs%253D&md5=95f0a579b4c852fbe80a54befb88b052</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm1498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1498%26sid%3Dliteratum%253Aachs%26aulast%3DWellbrock%26aufirst%3DC.%26aulast%3DKarasarides%26aufirst%3DM.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DThe%2520RAF%2520proteins%2520take%2520center%2520stage%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D875%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Davies, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bignell, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephen, P.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Mutation of the BRAF gene in human cancers</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">417</span> <span class="NLM_fpage">949</span> <span class="NLM_lpage">954</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=949-954&author=H.+Daviesauthor=G.+R.+Bignellauthor=C.+Coxauthor=P.+Stephen&title=Mutation+of+the+BRAF+gene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DBignell%26aufirst%3DG.%2BR.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DStephen%26aufirst%3DP.%26atitle%3DMutation%2520of%2520the%2520BRAF%2520gene%2520in%2520human%2520cancers%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D949%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Tuveson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, M.</span><span> </span><span class="NLM_article-title">BRAF as a potential therapeutic target in melanoma and other malignancies</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">95</span> <span class="NLM_lpage">98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=95-98&author=D.+A.+Tuvesonauthor=B.+L.+Weberauthor=M.+Herlyn&title=BRAF+as+a+potential+therapeutic+target+in+melanoma+and+other+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DWeber%26aufirst%3DB.%2BL.%26aulast%3DHerlyn%26aufirst%3DM.%26atitle%3DBRAF%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520melanoma%2520and%2520other%2520malignancies%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D4%26spage%3D95%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Garnett, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, R.</span><span> </span><span class="NLM_article-title">Guilty as charged: B-RAF is a human oncogene</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">313</span> <span class="NLM_lpage">319</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=313-319&author=M.+J.+Garnettauthor=R.+Marais&title=Guilty+as+charged%3A+B-RAF+is+a+human+oncogene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DGuilty%2520as%2520charged%253A%2520B-RAF%2520is%2520a%2520human%2520oncogene%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D4%26spage%3D313%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Chiloeches, A.; Marais, R.</span><span> </span><span class="NLM_article-title">Mitogen-activated protein kinase cascades as therapeutic targets in cancer</span>.  <span class="citation_source-book">Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins</span>; <span class="NLM_publisher-name">Humana Press Inc</span>.: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2002</span>; pp  <span class="NLM_fpage">179</span>− <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=179-206&author=A.+Chiloeches&author=R.+Marais&title=Targets+for+Cancer+Chemotherapy%3A+Transcription+Factors+and+Other+Nuclear+Proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChiloeches%26aufirst%3DA.%26atitle%3DMitogen-activated%2520protein%2520kinase%2520cascades%2520as%2520therapeutic%2520targets%2520in%2520cancer%26btitle%3DTargets%2520for%2520Cancer%2520Chemotherapy%253A%2520Transcription%2520Factors%2520and%2520Other%2520Nuclear%2520Proteins%26pub%3DHumana%2520Press%2520Inc%26date%3D2002%26spage%3D179%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity</span> <span class="citation_source-journal">Anti-Cancer Drug Des.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">1</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=1-6&author=E.+Woodauthor=R.+M.+Crosbyauthor=S.+Dickersonauthor=S.+V.+Fryeauthor=R.+Griffin&title=A+prodrug+approach+to+the+design+of+cRaf1+kinase+inhibitors+with+improved+cellular+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DDickerson%26aufirst%3DS.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGriffin%26aufirst%3DR.%26atitle%3DA%2520prodrug%2520approach%2520to%2520the%2520design%2520of%2520cRaf1%2520kinase%2520inhibitors%2520with%2520improved%2520cellular%2520activity%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D2001%26volume%3D16%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hall-Jackson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyers, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, N.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Paradoxical activation of Raf by a novel Raf inhibitor</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">559</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm070776b&amp;key=10.1016%2FS1074-5521%2899%2980088-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm070776b&amp;key=10421767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm070776b&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVynsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=559-568&author=C.+A.+Hall-Jacksonauthor=P.+A.+Eyersauthor=P.+Cohenauthor=F.+T.+Boyleauthor=N.+Hewitt&title=Paradoxical+activation+of+Raf+by+a+novel+Raf+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Paradoxical activation of raf by a novel raf inhibitor</span></div><div class="casAuthors">Hall-Jackson, Clare A.; Eyers, Patrick A.; Cohen, Philip; Goedert, Michel; Boyle, F. Tom; Hewitt, Neil; Plant, Helen; Hedge, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">559-568</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Raf is a proto-oncogene that is activated in response to growth factors or phorbol esters, and is thought to activate MAP kinase kinase-1 (MKK1) and hence the classical MAP kinase (MAPK) cascade.  The compd. ZM 336372 is identified as a potent and specific inhibitor of Raf isoforms in vitro.  Paradoxically, exposure of cells to ZM 336372 induces > 100-fold activation of c-Raf (measured in the absence of compd.), but without triggering any activation of MKK1 or p42 MAPK/ERK2.  The ZM 336372-induced activation of c-Raf occurs without any increase in the GTP-loading of Ras and is not prevented by inhibition of the MAPK cascade, protein kinase C or phosphatidylinositide 3-kinase.  ZM 336372 does not prevent growth factor or phorbol ester induced activation of MKK1 or p42 MAPK/ERK2, or reverse the phenotype of Ras- or Raf-transformed cell lines.  The only other protein kinase inhibited by ZM 336372 out of 20 tested was SAPK2/p38.  Although ZM 336372 is structurally unrelated to SB 203580, a potent inhibitor of SAPK2/p38, the mutation of Thr106→Met made SAPK2/p38 insensitive to ZM 336372 as well as to SB 203580.  Raf appears to suppress its own activation by a novel feedback loop, such that inhibition is always counterbalanced by reactivation.  These observations imply that some agonists reported to trigger the cellular activation of c-Raf might actually be inhibitors of this enzyme, and that compds. which inhibit the kinase activity of Raf might not be useful as anticancer drugs.  The binding sites for ZM 336372 and SB 203580 on Raf and SAPK2/p38 are likely to overlap.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo23oQKXswmRbVg90H21EOLACvtfcHk0lie9z6Stfvcdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVynsbo%253D&md5=93aa7dbc301a6f798be138df3e5a075c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980088-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980088-X%26sid%3Dliteratum%253Aachs%26aulast%3DHall-Jackson%26aufirst%3DC.%2BA.%26aulast%3DEyers%26aufirst%3DP.%2BA.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DHewitt%26aufirst%3DN.%26atitle%3DParadoxical%2520activation%2520of%2520Raf%2520by%2520a%2520novel%2520Raf%2520inhibitor%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D559%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Wilhelm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNabola, A.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">64</span> <span class="NLM_fpage">7099</span> <span class="NLM_lpage">7109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7099-7109&author=S.+M.+Wilhelmauthor=C.+Carterauthor=L.+Y.+Tangauthor=D.+Wilkieauthor=A.+McNabola&title=BAY+43-9006+exhibits+broad+spectrum+oral+antitumor+activity+and+targets+the+RAF%2FMEK%2FERK+pathway+and+receptor+tyrosine+kinases+involved+in+tumor+progression+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%2BM.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DL.%2BY.%26aulast%3DWilkie%26aufirst%3DD.%26aulast%3DMcNabola%26aufirst%3DA.%26atitle%3DBAY%252043-9006%2520exhibits%2520broad%2520spectrum%2520oral%2520antitumor%2520activity%2520and%2520targets%2520the%2520RAF%252FMEK%252FERK%2520pathway%2520and%2520receptor%2520tyrosine%2520kinases%2520involved%2520in%2520tumor%2520progression%2520and%2520angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7099%26epage%3D7109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, L. E.</span><span> </span><span class="NLM_article-title">Raf pathway inhibition in oncology</span> <span class="citation_source-journal">Curr. Opin. Investig. Drugs</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">1436</span> <span class="NLM_lpage">1441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=1436-1441&author=G.+Bollagauthor=S.+Freemanauthor=G.+F.+Lyonsauthor=L.+E.+Post&title=Raf+pathway+inhibition+in+oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DFreeman%26aufirst%3DS.%26aulast%3DLyons%26aufirst%3DG.%2BF.%26aulast%3DPost%26aufirst%3DL.%2BE.%26atitle%3DRaf%2520pathway%2520inhibition%2520in%2520oncology%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2004%26volume%3D4%26spage%3D1436%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, S. M.</span><span> </span><span class="NLM_article-title">Recent advances in the research and development of RAF kinase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">1071</span> <span class="NLM_lpage">1089</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm070776b&amp;key=10.2174%2F156802606777812077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm070776b&amp;key=16842147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm070776b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1071-1089&author=R.+A.+Smithauthor=J.+Dumasauthor=L.+Adnaneauthor=S.+M.+Wilhelm&title=Recent+advances+in+the+research+and+development+of+RAF+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the research and development of RAF kinase inhibitors</span></div><div class="casAuthors">Smith, Roger A.; Dumas, Jacques; Adnane, Lila; Wilhelm, Scott M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1071-1089</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The RAS-RAF-MEK-ERK signaling pathway (ERK pathway) plays a key role in tumorigenesis and cancer progression.  Mutations of RAS or B-RAF lead to a constitutive activation of the ERK pathway, which ultimately results in increased cell division, and cell survival.  This review article focuses on the recent literature related to ERK pathway inhibitors, with a particular emphasis on RAF kinase inhibitors.  Preclin. and clin. data for the RAF kinase inhibitor sorafenib (BAY 43-9006 tosylate), that was recently approved in the US for the treatment of advanced renal cell carcinoma, are also outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr4CQGGdqnEbVg90H21EOLACvtfcHk0lie9z6Stfvcdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7o%253D&md5=3a31ae50cbb92d9c35b2df39589cbeba</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F156802606777812077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812077%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DAdnane%26aufirst%3DL.%26aulast%3DWilhelm%26aufirst%3DS.%2BM.%26atitle%3DRecent%2520advances%2520in%2520the%2520research%2520and%2520development%2520of%2520RAF%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1071%26epage%3D1089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Batt, D. B.; Bold, G.; Kim, S.; Ramsey, T. M.; Sabio, M. L.</span> <span class="citation_source-book">Use of Isoquinoline Derivatives for Treating Cancer and MAP Kinase Related Diseases</span>; <span class="NLM_publisher-name">Novartis AG</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>, <span class="NLM_year">2004</span>; p  <span class="NLM_fpage">85</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=85&author=D.+B.+Batt&author=G.+Bold&author=S.+Kim&author=T.+M.+Ramsey&author=M.+L.+Sabio&title=Use+of+Isoquinoline+Derivatives+for+Treating+Cancer+and+MAP+Kinase+Related+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBatt%26aufirst%3DD.%2BB.%26btitle%3DUse%2520of%2520Isoquinoline%2520Derivatives%2520for%2520Treating%2520Cancer%2520and%2520MAP%2520Kinase%2520Related%2520Diseases%26pub%3DNovartis%2520AG%26date%3D2004%26spage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Fink, C. A.; Perez, L. B.; Ramsey, T. M.; Yusuf, N.; Versace, R. W.</span><span class="NLM_etal"></span> <span class="citation_source-book">1,4-Disubstituted Isoquinoline Derivatives as RAF-Kinase Inhibitors Useful for the Treatment of Proliferative Diseases</span>; <span class="NLM_publisher-name">Novartis AG</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>, <span class="NLM_year">2005</span>; p  <span class="NLM_fpage">144</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=144&author=C.+A.+Fink&author=L.+B.+Perez&author=T.+M.+Ramsey&author=N.+Yusuf&author=R.+W.+Versace&title=1%2C4-Disubstituted+Isoquinoline+Derivatives+as+RAF-Kinase+Inhibitors+Useful+for+the+Treatment+of+Proliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFink%26aufirst%3DC.%2BA.%26btitle%3D1%252C4-Disubstituted%2520Isoquinoline%2520Derivatives%2520as%2520RAF-Kinase%2520Inhibitors%2520Useful%2520for%2520the%2520Treatment%2520of%2520Proliferative%2520Diseases%26pub%3DNovartis%2520AG%26date%3D2005%26spage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Takle, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">The identification of potent and selective imidazole-based inhibitors of B-RAF kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">378</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=378-381&author=A.+K.+Takleauthor=M.+J.+B.+Brownauthor=S.+Daviesauthor=D.+K.+Deanauthor=G.+Francis&title=The+identification+of+potent+and+selective+imidazole-based+inhibitors+of+B-RAF+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DBrown%26aufirst%3DM.%2BJ.%2BB.%26aulast%3DDavies%26aufirst%3DS.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DFrancis%26aufirst%3DG.%26atitle%3DThe%2520identification%2520of%2520potent%2520and%2520selective%2520imidazole-based%2520inhibitors%2520of%2520B-RAF%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D378%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">King, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batorsky, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, H. T.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">66</span> <span class="NLM_fpage">11100</span> <span class="NLM_lpage">11105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=11100-11105&author=A.+J.+Kingauthor=D.+R.+Patrickauthor=R.+S.+Batorskyauthor=M.+L.+Hoauthor=H.+T.+Do&title=Demonstration+of+a+genetic+therapeutic+index+for+tumors+expressing+oncogenic+BRAF+by+the+kinase+inhibitor+SB-590885"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BJ.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DBatorsky%26aufirst%3DR.%2BS.%26aulast%3DHo%26aufirst%3DM.%2BL.%26aulast%3DDo%26aufirst%3DH.%2BT.%26atitle%3DDemonstration%2520of%2520a%2520genetic%2520therapeutic%2520index%2520for%2520tumors%2520expressing%2520oncogenic%2520BRAF%2520by%2520the%2520kinase%2520inhibitor%2520SB-590885%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D11100%26epage%3D11105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ahmad, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, T.</span><span> </span><span class="NLM_article-title">Kinase inhibition with BAY 43-9006 in renal cell carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">10</span> <span class="NLM_fpage">6388S</span> <span class="NLM_lpage">6392S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=6388S-6392S&author=T.+Ahmadauthor=T.+Eisen&title=Kinase+inhibition+with+BAY+43-9006+in+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DT.%26aulast%3DEisen%26aufirst%3DT.%26atitle%3DKinase%2520inhibition%2520with%2520BAY%252043-9006%2520in%2520renal%2520cell%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D6388S%26epage%3D6392S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Niculescu-Duvaz, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittaker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedlos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Novel inhibitors of B-RAF based on a disubstituted pyrazine scaffold. Generation of a nanomolar lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">407</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050983g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=407-416&author=I.+Niculescu-Duvazauthor=E.+Romanauthor=S.+R.+Wittakerauthor=F.+Friedlosauthor=R.+Kirk&title=Novel+inhibitors+of+B-RAF+based+on+a+disubstituted+pyrazine+scaffold.+Generation+of+a+nanomolar+lead"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm050983g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050983g%26sid%3Dliteratum%253Aachs%26aulast%3DNiculescu-Duvaz%26aufirst%3DI.%26aulast%3DRoman%26aufirst%3DE.%26aulast%3DWittaker%26aufirst%3DS.%2BR.%26aulast%3DFriedlos%26aufirst%3DF.%26aulast%3DKirk%26aufirst%3DR.%26atitle%3DNovel%2520inhibitors%2520of%2520B-RAF%2520based%2520on%2520a%2520disubstituted%2520pyrazine%2520scaffold.%2520Generation%2520of%2520a%2520nanomolar%2520lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Wan, P. T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnett, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niculescu-Duvaz, D.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Mechanism of activation of of the RAF/ERK signaling pathway by oncogenic mutations of B-RAF</span> <span class="citation_source-journal">Cell</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">116</span> <span class="NLM_fpage">855</span> <span class="NLM_lpage">867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=855-867&author=P.+T.+C.+Wanauthor=M.+J.+Garnettauthor=M.+S.+Roeauthor=S.+Leeauthor=D.+Niculescu-Duvaz&title=Mechanism+of+activation+of+of+the+RAF%2FERK+signaling+pathway+by+oncogenic+mutations+of+B-RAF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DP.%2BT.%2BC.%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DRoe%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DNiculescu-Duvaz%26aufirst%3DD.%26atitle%3DMechanism%2520of%2520activation%2520of%2520of%2520the%2520RAF%252FERK%2520signaling%2520pathway%2520by%2520oncogenic%2520mutations%2520of%2520B-RAF%26jtitle%3DCell%26date%3D2004%26volume%3D116%26spage%3D855%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Liao, J. J.-L.</span><span> </span><span class="NLM_article-title">Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">409</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm070776b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J.+J.-L.+Liao&title=Molecular+recognition+of+protein+kinase+binding+pockets+for+design+of+potent+and+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lhzi3TWjnNVjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.-L.%26atitle%3DMolecular%2520recognition%2520of%2520protein%2520kinase%2520binding%2520pockets%2520for%2520design%2520of%2520potent%2520and%2520selective%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Wolfe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadighi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Simple, efficient catalyst system for the palladium-catalyzed amination of aryl chlorides, bromides and triflates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">65</span> <span class="NLM_fpage">1158</span> <span class="NLM_lpage">1174</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo991699y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=1158-1174&author=J.+P.+Wolfeauthor=H.+Tomoriauthor=J.+P.+Sadighiauthor=J.+Yinauthor=S.+L.+Buchwald&title=Simple%2C+efficient+catalyst+system+for+the+palladium-catalyzed+amination+of+aryl+chlorides%2C+bromides+and+triflates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo991699y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo991699y%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26aulast%3DTomori%26aufirst%3DH.%26aulast%3DSadighi%26aufirst%3DJ.%2BP.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DSimple%252C%2520efficient%2520catalyst%2520system%2520for%2520the%2520palladium-catalyzed%2520amination%2520of%2520aryl%2520chlorides%252C%2520bromides%2520and%2520triflates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D1158%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Grasa, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viciu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, S. P.</span><span> </span><span class="NLM_article-title">Amination reaction of aryl halides with nitrogen-containing reagents mediated by palladium/imidazolium salts</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">66</span> <span class="NLM_fpage">7729</span> <span class="NLM_lpage">7737</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo010613%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=7729-7737&author=G.+A.+Grasaauthor=M.+S.+Viciuauthor=J.+Huangauthor=S.+P.+Nolan&title=Amination+reaction+of+aryl+halides+with+nitrogen-containing+reagents+mediated+by+palladium%2Fimidazolium+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo010613%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010613%252B%26sid%3Dliteratum%253Aachs%26aulast%3DGrasa%26aufirst%3DG.%2BA.%26aulast%3DViciu%26aufirst%3DM.%2BS.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DNolan%26aufirst%3DS.%2BP.%26atitle%3DAmination%2520reaction%2520of%2520aryl%2520halides%2520with%2520nitrogen-containing%2520reagents%2520mediated%2520by%2520palladium%252Fimidazolium%2520salts%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D7729%26epage%3D7737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kotha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">khashinath, D.</span><span> </span><span class="NLM_article-title">Recent applications of the Suzuki−Miyaura cross coupling reactions in organic synthesis</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">58</span> <span class="NLM_fpage">9633</span> <span class="NLM_lpage">9695</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=9633-9695&author=S.+Kothaauthor=K.+Lahiriauthor=D.+khashinath&title=Recent+applications+of+the+Suzuki%E2%88%92Miyaura+cross+coupling+reactions+in+organic+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKotha%26aufirst%3DS.%26aulast%3DLahiri%26aufirst%3DK.%26aulast%3Dkhashinath%26aufirst%3DD.%26atitle%3DRecent%2520applications%2520of%2520the%2520Suzuki%25E2%2588%2592Miyaura%2520cross%2520coupling%2520reactions%2520in%2520organic%2520synthesis%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D9633%26epage%3D9695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Littke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, G. C.</span><span> </span><span class="NLM_article-title">Palladium catalysed coupling reaction of aryl chlorides</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">41</span> <span class="NLM_fpage">4176</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=4176-4211&author=A.+Littkeauthor=G.+C.+Fu&title=Palladium+catalysed+coupling+reaction+of+aryl+chlorides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLittke%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DG.%2BC.%26atitle%3DPalladium%2520catalysed%2520coupling%2520reaction%2520of%2520aryl%2520chlorides%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D4176%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witteking, M.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against Imatinib-resistant ABL mutants</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">66</span> <span class="NLM_fpage">5790</span> <span class="NLM_lpage">5797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=5790-5797&author=J.+S.+Tokarskiauthor=J.+A.+Newittauthor=C.+Y.+J.+Changauthor=J.+D.+Chengauthor=M.+Witteking&title=The+structure+of+Dasatinib+%28BMS-354825%29+bound+to+activated+ABL+kinase+domain+elucidates+its+inhibitory+activity+against+Imatinib-resistant+ABL+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DChang%26aufirst%3DC.%2BY.%2BJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DWitteking%26aufirst%3DM.%26atitle%3DThe%2520structure%2520of%2520Dasatinib%2520%2528BMS-354825%2529%2520bound%2520to%2520activated%2520ABL%2520kinase%2520domain%2520elucidates%2520its%2520inhibitory%2520activity%2520against%2520Imatinib-resistant%2520ABL%2520mutants%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D5790%26epage%3D5797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula  Ruiz-Castillo</span> and <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12564-12649. <a href="https://doi.org/10.1021/acs.chemrev.6b00512" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00512%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DApplications%252Bof%252BPalladium-Catalyzed%252BC%2525E2%252580%252593N%252BCross-Coupling%252BReactions%26aulast%3DRuiz-Castillo%26aufirst%3DPaula%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03082016%26date%3D30092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12564%26epage%3D12649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srimanta  Manna</span>, <span class="hlFld-ContribAuthor ">Polina O.  Serebrennikova</span>, <span class="hlFld-ContribAuthor ">Irina A.  Utepova</span>, <span class="hlFld-ContribAuthor ">Andrey P.  Antonchick</span>, and <span class="hlFld-ContribAuthor ">Oleg N.  Chupakhin</span>  . </span><span class="cited-content_cbyCitation_article-title">Hypervalent Iodine(III) in Direct Oxidative Amination of Arenes with Heteroaromatic Amines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (18)
                                     , 4588-4591. <a href="https://doi.org/10.1021/acs.orglett.5b02320" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b02320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b02320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b02320%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DHypervalent%252BIodine%252528III%252529%252Bin%252BDirect%252BOxidative%252BAmination%252Bof%252BArenes%252Bwith%252BHeteroaromatic%252BAmines%26aulast%3DManna%26aufirst%3DSrimanta%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10082015%26date%3D02092015%26date%3D18092015%26volume%3D17%26issue%3D18%26spage%3D4588%26epage%3D4591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreu  Vidal-Albalat</span>, <span class="hlFld-ContribAuthor ">Santiago  Rodríguez</span>, and <span class="hlFld-ContribAuthor ">Florenci V.  González</span>  . </span><span class="cited-content_cbyCitation_article-title">Nitroepoxides as Versatile Precursors to 1,4-Diamino Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (6)
                                     , 1752-1755. <a href="https://doi.org/10.1021/ol500444z" title="DOI URL">https://doi.org/10.1021/ol500444z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol500444z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol500444z%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DNitroepoxides%252Bas%252BVersatile%252BPrecursors%252Bto%252B1%25252C4-Diamino%252BHeterocycles%26aulast%3DVidal-Albalat%26aufirst%3DAndreu%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11022014%26date%3D03032014%26date%3D21032014%26volume%3D16%26issue%3D6%26spage%3D1752%26epage%3D1755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parvinder Pal  Singh</span>, <span class="hlFld-ContribAuthor ">Sravan Kumar  Aithagani</span>, <span class="hlFld-ContribAuthor ">Mahipal  Yadav</span>, <span class="hlFld-ContribAuthor ">Varun Pratap  Singh</span>, and <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>  . </span><span class="cited-content_cbyCitation_article-title">Iron-catalyzed Cross-Coupling of Electron-Deficient Heterocycles and Quinone with Organoboron Species via Innate C–H Functionalization: Application in Total Synthesis of Pyrazine Alkaloid Botryllazine A. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (6)
                                     , 2639-2648. <a href="https://doi.org/10.1021/jo302797r" title="DOI URL">https://doi.org/10.1021/jo302797r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo302797r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo302797r%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIron-catalyzed%252BCross-Coupling%252Bof%252BElectron-Deficient%252BHeterocycles%252Band%252BQuinone%252Bwith%252BOrganoboron%252BSpecies%252Bvia%252BInnate%252BC%2525E2%252580%252593H%252BFunctionalization%25253A%252BApplication%252Bin%252BTotal%252BSynthesis%252Bof%252BPyrazine%252BAlkaloid%252BBotryllazine%252BA%26aulast%3DSingh%26aufirst%3DParvinder%2BPal%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D02012013%26date%3D27022013%26date%3D15032013%26date%3D19022013%26volume%3D78%26issue%3D6%26spage%3D2639%26epage%3D2648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Yang</span>, <span class="hlFld-ContribAuthor ">Jin  Qin</span>, <span class="hlFld-ContribAuthor ">Huanxiang  Liu</span>, and <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>  . </span><span class="cited-content_cbyCitation_article-title">Molecular Dynamics Simulation, Free Energy Calculation and Structure-Based 3D-QSAR Studies of B-RAF Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (3)
                                     , 680-692. <a href="https://doi.org/10.1021/ci100427j" title="DOI URL">https://doi.org/10.1021/ci100427j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci100427j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci100427j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DMolecular%252BDynamics%252BSimulation%25252C%252BFree%252BEnergy%252BCalculation%252Band%252BStructure-Based%252B3D-QSAR%252BStudies%252Bof%252BB-RAF%252BKinase%252BInhibitors%26aulast%3DYang%26aufirst%3DYing%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D26102010%26date%3D22022011%26date%3D28032011%26volume%3D51%26issue%3D3%26spage%3D680%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brett P.  Fors</span> and <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>. </span><span class="cited-content_cbyCitation_article-title">A Multiligand Based Pd Catalyst for C−N Cross-Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2010,</strong> <em>132 </em>
                                    (45)
                                     , 15914-15917. <a href="https://doi.org/10.1021/ja108074t" title="DOI URL">https://doi.org/10.1021/ja108074t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja108074t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja108074t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DA%252BMultiligand%252BBased%252BPd%252BCatalyst%252Bfor%252BC%2525E2%252588%252592N%252BCross-Coupling%252BReactions%26aulast%3DFors%26aufirst%3DBrett%2BP.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D7%252009%25202010%26date%3D27102010%26date%3D17112010%26volume%3D132%26issue%3D45%26spage%3D15914%26epage%3D15917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bart M. J. M.  Suijkerbuijk</span>, <span class="hlFld-ContribAuthor ">Ion  Niculescu-Duvaz</span>, <span class="hlFld-ContribAuthor ">Catherine  Gaulon</span>, <span class="hlFld-ContribAuthor ">Harmen P.  Dijkstra</span>, <span class="hlFld-ContribAuthor ">Dan  Niculescu-Duvaz</span>, <span class="hlFld-ContribAuthor ">Delphine  Ménard</span>, <span class="hlFld-ContribAuthor ">Alfonso  Zambon</span>, <span class="hlFld-ContribAuthor ">Arnaud  Nourry</span>, <span class="hlFld-ContribAuthor ">Lawrence  Davies</span>, <span class="hlFld-ContribAuthor ">Helen A.  Manne</span>, <span class="hlFld-ContribAuthor ">Frank  Friedlos</span>, <span class="hlFld-ContribAuthor ">Lesley M.  Ogilvie</span>, <span class="hlFld-ContribAuthor ">Douglas  Hedley</span>, <span class="hlFld-ContribAuthor ">Filipa  Lopes</span>, <span class="hlFld-ContribAuthor ">Natasha P. U.  Preece</span>, <span class="hlFld-ContribAuthor ">Javier  Moreno-Farre</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Ruth  Kirk</span>, <span class="hlFld-ContribAuthor ">Steven  Whittaker</span>, <span class="hlFld-ContribAuthor ">Richard  Marais</span> and <span class="hlFld-ContribAuthor ">Caroline J.  Springer</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Novel, Highly Potent Inhibitors of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF): Increasing Cellular Potency through Optimization of a Distal Heteroaromatic Group. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (7)
                                     , 2741-2756. <a href="https://doi.org/10.1021/jm900607f" title="DOI URL">https://doi.org/10.1021/jm900607f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm900607f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm900607f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BNovel%25252C%252BHighly%252BPotent%252BInhibitors%252Bof%252BV-RAF%252BMurine%252BSarcoma%252BViral%252BOncogene%252BHomologue%252BB1%252B%252528BRAF%252529%25253A%252BIncreasing%252BCellular%252BPotency%252Bthrough%252BOptimization%252Bof%252Ba%252BDistal%252BHeteroaromatic%252BGroup%26aulast%3DSuijkerbuijk%26aufirst%3DBart%2BM.%2BJ.%2BM.%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D08052009%26date%3D03032010%26date%3D08042010%26volume%3D53%26issue%3D7%26spage%3D2741%26epage%3D2756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Delphine  Ménard</span>, <span class="hlFld-ContribAuthor ">Ion  Niculescu-Duvaz</span>, <span class="hlFld-ContribAuthor ">Harmen P.  Dijkstra</span>, <span class="hlFld-ContribAuthor ">Dan  Niculescu-Duvaz</span>, <span class="hlFld-ContribAuthor ">Bart M. J. M.  Suijkerbuijk</span>, <span class="hlFld-ContribAuthor ">Alfonso  Zambon</span>, <span class="hlFld-ContribAuthor ">Arnaud  Nourry</span>, <span class="hlFld-ContribAuthor ">Esteban  Roman</span>, <span class="hlFld-ContribAuthor ">Lawrence  Davies</span>, <span class="hlFld-ContribAuthor ">Helen A.  Manne</span>, <span class="hlFld-ContribAuthor ">Frank  Friedlos</span>, <span class="hlFld-ContribAuthor ">Ruth  Kirk</span>, <span class="hlFld-ContribAuthor ">Steven  Whittaker</span>, <span class="hlFld-ContribAuthor ">Adrian  Gill</span>, <span class="hlFld-ContribAuthor ">Richard D.  Taylor</span>, <span class="hlFld-ContribAuthor ">Richard  Marais</span> and <span class="hlFld-ContribAuthor ">Caroline J.  Springer</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Potent BRAF Inhibitors: Toward 1 nM Compounds through Optimization of the Central Phenyl Ring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (13)
                                     , 3881-3891. <a href="https://doi.org/10.1021/jm900242c" title="DOI URL">https://doi.org/10.1021/jm900242c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm900242c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm900242c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BPotent%252BBRAF%252BInhibitors%25253A%252BToward%252B1%252BnM%252BCompounds%252Bthrough%252BOptimization%252Bof%252Bthe%252BCentral%252BPhenyl%252BRing%26aulast%3DM%25C3%25A9nard%26aufirst%3DDelphine%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D25%252002%25202009%26date%3D27052009%26date%3D09072009%26volume%3D52%26issue%3D13%26spage%3D3881%26epage%3D3891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alisa D.  Kharlamova</span>, <span class="hlFld-ContribAuthor ">Anton S.  Abel</span>, <span class="hlFld-ContribAuthor ">Alexei D.  Averin</span>, <span class="hlFld-ContribAuthor ">Olga A.  Maloshitskaya</span>, <span class="hlFld-ContribAuthor ">Vitaly A.  Roznyatovskiy</span>, <span class="hlFld-ContribAuthor ">Evgenii N.  Savelyev</span>, <span class="hlFld-ContribAuthor ">Boris S.  Orlinson</span>, <span class="hlFld-ContribAuthor ">Ivan A.  Novakov</span>, <span class="hlFld-ContribAuthor ">Irina P.  Beletskaya</span>. </span><span class="cited-content_cbyCitation_article-title">Mono- and Diamination of 4,6-Dichloropyrimidine, 2,6-Dichloropyrazine and 1,3-Dichloroisoquinoline with Adamantane-Containing Amines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 1910. <a href="https://doi.org/10.3390/molecules26071910" title="DOI URL">https://doi.org/10.3390/molecules26071910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26071910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26071910%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMono-%252Band%252BDiamination%252Bof%252B4%25252C6-Dichloropyrimidine%25252C%252B2%25252C6-Dichloropyrazine%252Band%252B1%25252C3-Dichloroisoquinoline%252Bwith%252BAdamantane-Containing%252BAmines%26aulast%3DKharlamova%26aufirst%3DAlisa%2BD.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronica  Rendo</span>, <span class="hlFld-ContribAuthor ">Ivaylo  Stoimenov</span>, <span class="hlFld-ContribAuthor ">André  Mateus</span>, <span class="hlFld-ContribAuthor ">Elin  Sjöberg</span>, <span class="hlFld-ContribAuthor ">Richard  Svensson</span>, <span class="hlFld-ContribAuthor ">Anna-Lena  Gustavsson</span>, <span class="hlFld-ContribAuthor ">Lars  Johansson</span>, <span class="hlFld-ContribAuthor ">Adrian  Ng</span>, <span class="hlFld-ContribAuthor ">Casey  OʼBrien</span>, <span class="hlFld-ContribAuthor ">Marios  Giannakis</span>, <span class="hlFld-ContribAuthor ">Per  Artursson</span>, <span class="hlFld-ContribAuthor ">Peter  Nygren</span>, <span class="hlFld-ContribAuthor ">Ian  Cheong</span>, <span class="hlFld-ContribAuthor ">Tobias  Sjöblom</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-15111-4" title="DOI URL">https://doi.org/10.1038/s41467-020-15111-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-15111-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-15111-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DExploiting%252Bloss%252Bof%252Bheterozygosity%252Bfor%252Ballele-selective%252Bcolorectal%252Bcancer%252Bchemotherapy%26aulast%3DRendo%26aufirst%3DVeronica%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaydeepsinh  Chavda</span>, <span class="hlFld-ContribAuthor ">Hardik  Bhatt</span>. </span><span class="cited-content_cbyCitation_article-title">Systemic review on B-RafV600E mutation as potential therapeutic target for the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112675. <a href="https://doi.org/10.1016/j.ejmech.2020.112675" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112675%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSystemic%252Breview%252Bon%252BB-RafV600E%252Bmutation%252Bas%252Bpotential%252Btherapeutic%252Btarget%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DChavda%26aufirst%3DJaydeepsinh%26date%3D2020%26volume%3D206%26spage%3D112675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gao-Feng  Zha</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>, <span class="hlFld-ContribAuthor ">Bahaa G.M.  Youssif</span>, <span class="hlFld-ContribAuthor ">Muhammad Wahab  Amjad</span>, <span class="hlFld-ContribAuthor ">Maria Abdul Ghafoor  Raja</span>, <span class="hlFld-ContribAuthor ">Ahmed H.  Abdelazeem</span>, <span class="hlFld-ContribAuthor ">Syed Nasir Abbas  Bukhari</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>135 </em>, 34-48. <a href="https://doi.org/10.1016/j.ejmech.2017.04.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotential%252Banticancer%252Bmulti-targeted%252Bligustrazine%252Bbased%252Bcyclohexanone%252Band%252Boxime%252Banalogs%252Bovercoming%252Bthe%252Bcancer%252Bmultidrug%252Bresistance%26aulast%3DZha%26aufirst%3DGao-Feng%26date%3D2017%26volume%3D135%26spage%3D34%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua  Almond-Thynne</span>, <span class="hlFld-ContribAuthor ">David C.  Blakemore</span>, <span class="hlFld-ContribAuthor ">David C.  Pryde</span>, <span class="hlFld-ContribAuthor ">Alan C.  Spivey</span>. </span><span class="cited-content_cbyCitation_article-title">Site-selective Suzuki–Miyaura coupling of heteroaryl halides – understanding the trends for pharmaceutically important classes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     , 40-62. <a href="https://doi.org/10.1039/C6SC02118B" title="DOI URL">https://doi.org/10.1039/C6SC02118B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6SC02118B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6SC02118B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DSite-selective%252BSuzuki%2525E2%252580%252593Miyaura%252Bcoupling%252Bof%252Bheteroaryl%252Bhalides%252B%2525E2%252580%252593%252Bunderstanding%252Bthe%252Btrends%252Bfor%252Bpharmaceutically%252Bimportant%252Bclasses%26aulast%3DAlmond-Thynne%26aufirst%3DJoshua%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D40%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rameshwar Prasad  Pandit</span>, <span class="hlFld-ContribAuthor ">Sung Hong  Kim</span>, <span class="hlFld-ContribAuthor ">Yong Rok  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Iron-Catalyzed Annulation of 1,2-Diamines and Diazodicarbonyls for Diverse and Polyfunctionalized Quinoxalines, Pyrazines, and Benzoquinoxalines in Water. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2016,</strong> <em>358 </em>
                                    (22)
                                     , 3586-3599. <a href="https://doi.org/10.1002/adsc.201600503" title="DOI URL">https://doi.org/10.1002/adsc.201600503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201600503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201600503%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DIron-Catalyzed%252BAnnulation%252Bof%252B1%25252C2-Diamines%252Band%252BDiazodicarbonyls%252Bfor%252BDiverse%252Band%252BPolyfunctionalized%252BQuinoxalines%25252C%252BPyrazines%25252C%252Band%252BBenzoquinoxalines%252Bin%252BWater%26aulast%3DPandit%26aufirst%3DRameshwar%2BPrasad%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D22%26spage%3D3586%26epage%3D3599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milind  Saudi</span>, <span class="hlFld-ContribAuthor ">Joanna  Zmurko</span>, <span class="hlFld-ContribAuthor ">Suzanne  Kaptein</span>, <span class="hlFld-ContribAuthor ">Jef  Rozenski</span>, <span class="hlFld-ContribAuthor ">Bharat  Gadakh</span>, <span class="hlFld-ContribAuthor ">Patrick  Chaltin</span>, <span class="hlFld-ContribAuthor ">Arnaud  Marchand</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">Arthur  Van Aerschot</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virus. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>121 </em>, 158-168. <a href="https://doi.org/10.1016/j.ejmech.2016.05.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.05.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.05.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bstrategy%252Band%252Bantiviral%252Bevaluation%252Bof%252Bdiamide%252Bcontaining%252Bheterocycles%252Btargeting%252Bdengue%252Band%252Byellow%252Bfever%252Bvirus%26aulast%3DSaudi%26aufirst%3DMilind%26date%3D2016%26volume%3D121%26spage%3D158%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hala Bakr  El-Nassan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in the identification of BRAF inhibitors as anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>72 </em>, 170-205. <a href="https://doi.org/10.1016/j.ejmech.2013.11.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.11.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.11.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252Bthe%252Bidentification%252Bof%252BBRAF%252Binhibitors%252Bas%252Banti-cancer%252Bagents%26aulast%3DEl-Nassan%26aufirst%3DHala%2BBakr%26date%3D2014%26volume%3D72%26spage%3D170%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Juan  Qin</span>, <span class="hlFld-ContribAuthor ">Man  Xing</span>, <span class="hlFld-ContribAuthor ">Ya-Liang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jigar A.  Makawana</span>, <span class="hlFld-ContribAuthor ">Ai-Qin  Jiang</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of (1,3-diphenyl-1H-pyrazol-4-yl) methyl benzoate derivatives as potential BRAF
              V600E
              inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (95)
                                     , 52702-52711. <a href="https://doi.org/10.1039/C4RA08708A" title="DOI URL">https://doi.org/10.1039/C4RA08708A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA08708A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA08708A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B%2525281%25252C3-diphenyl-1H-pyrazol-4-yl%252529%252Bmethyl%252Bbenzoate%252Bderivatives%252Bas%252Bpotential%252BBRAF%252BV600E%252Binhibitors%26aulast%3DQin%26aufirst%3DYa-Juan%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D95%26spage%3D52702%26epage%3D52711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omprakash  Tanwar</span>, <span class="hlFld-ContribAuthor ">Akranth  Marella</span>, <span class="hlFld-ContribAuthor ">Sandeep  Shrivastava</span>, <span class="hlFld-ContribAuthor ">M.  Mumtaz Alam</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhtar</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore model generation and 3D-QSAR analysis of N-acyl and N-aroylpyrazolines for enzymatic and cellular B-Raf kinase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (5)
                                     , 2174-2187. <a href="https://doi.org/10.1007/s00044-012-0210-z" title="DOI URL">https://doi.org/10.1007/s00044-012-0210-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0210-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0210-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DPharmacophore%252Bmodel%252Bgeneration%252Band%252B3D-QSAR%252Banalysis%252Bof%252BN-acyl%252Band%252BN-aroylpyrazolines%252Bfor%252Benzymatic%252Band%252Bcellular%252BB-Raf%252Bkinase%252Binhibition%26aulast%3DTanwar%26aufirst%3DOmprakash%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D5%26spage%3D2174%26epage%3D2187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Niculescu-Duvaz</span>, <span class="hlFld-ContribAuthor ">Ion  Niculescu-Duvaz</span>, <span class="hlFld-ContribAuthor ">Bart M.J.M.  Suijkerbuijk</span>, <span class="hlFld-ContribAuthor ">Delphine  Ménard</span>, <span class="hlFld-ContribAuthor ">Alfonso  Zambon</span>, <span class="hlFld-ContribAuthor ">Lawrence  Davies</span>, <span class="hlFld-ContribAuthor ">Jean-Francois  Pons</span>, <span class="hlFld-ContribAuthor ">Steven  Whittaker</span>, <span class="hlFld-ContribAuthor ">Richard  Marais</span>, <span class="hlFld-ContribAuthor ">Caroline J.  Springer</span>. </span><span class="cited-content_cbyCitation_article-title">Potent BRAF kinase inhibitors based on 2,4,5-trisubstituted imidazole with naphthyl and benzothiophene 4-substituents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (5)
                                     , 1284-1304. <a href="https://doi.org/10.1016/j.bmc.2012.12.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.12.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.12.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPotent%252BBRAF%252Bkinase%252Binhibitors%252Bbased%252Bon%252B2%25252C4%25252C5-trisubstituted%252Bimidazole%252Bwith%252Bnaphthyl%252Band%252Bbenzothiophene%252B4-substituents%26aulast%3DNiculescu-Duvaz%26aufirst%3DDan%26date%3D2013%26volume%3D21%26issue%3D5%26spage%3D1284%26epage%3D1304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zaheer  Ul-Haq</span>, <span class="hlFld-ContribAuthor ">Uzma  Mahmood</span>, <span class="hlFld-ContribAuthor ">Sauleha  Reza</span>. </span><span class="cited-content_cbyCitation_article-title">A combined 3D-QSAR and molecular docking strategy to understand the binding mechanism of V600EB-RAF inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2012,</strong> <em>16 </em>
                                    (4)
                                     , 771-785. <a href="https://doi.org/10.1007/s11030-012-9395-9" title="DOI URL">https://doi.org/10.1007/s11030-012-9395-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-012-9395-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-012-9395-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DA%252Bcombined%252B3D-QSAR%252Band%252Bmolecular%252Bdocking%252Bstrategy%252Bto%252Bunderstand%252Bthe%252Bbinding%252Bmechanism%252Bof%252BV600EB-RAF%252Binhibitors%26aulast%3DUl-Haq%26aufirst%3DZaheer%26date%3D2012%26date%3D2012%26volume%3D16%26issue%3D4%26spage%3D771%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atif A.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Ashley K.  Sherman</span>, <span class="hlFld-ContribAuthor ">Bruce R.  Pawel</span>. </span><span class="cited-content_cbyCitation_article-title">Expression of therapeutic targets in Ewing sarcoma family tumors. </span><span class="cited-content_cbyCitation_journal-name">Human Pathology</span><span> <strong>2012,</strong> <em>43 </em>
                                    (7)
                                     , 1077-1083. <a href="https://doi.org/10.1016/j.humpath.2011.09.001" title="DOI URL">https://doi.org/10.1016/j.humpath.2011.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.humpath.2011.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.humpath.2011.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Pathology%26atitle%3DExpression%252Bof%252Btherapeutic%252Btargets%252Bin%252BEwing%252Bsarcoma%252Bfamily%252Btumors%26aulast%3DAhmed%26aufirst%3DAtif%2BA.%26date%3D2012%26volume%3D43%26issue%3D7%26spage%3D1077%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandhya  Badrinarayanan</span>, <span class="hlFld-ContribAuthor ">Jonathan  Sperry</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazine alkaloids via dimerization of amino acid-derived α-amino aldehydes: biomimetic synthesis of 2,5-diisopropylpyrazine, 2,5-bis(3-indolylmethyl)pyrazine and actinopolymorphol C. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2012,</strong> <em>10 </em>
                                    (10)
                                     , 2126. <a href="https://doi.org/10.1039/c2ob06935k" title="DOI URL">https://doi.org/10.1039/c2ob06935k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2ob06935k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2ob06935k%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPyrazine%252Balkaloids%252Bvia%252Bdimerization%252Bof%252Bamino%252Bacid-derived%252B%2525CE%2525B1-amino%252Baldehydes%25253A%252Bbiomimetic%252Bsynthesis%252Bof%252B2%25252C5-diisopropylpyrazine%25252C%252B2%25252C5-bis%2525283-indolylmethyl%252529pyrazine%252Band%252Bactinopolymorphol%252BC%26aulast%3DBadrinarayanan%26aufirst%3DSandhya%26date%3D2012%26volume%3D10%26issue%3D10%26spage%3D2126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathalie  Dhomen</span>, <span class="hlFld-ContribAuthor ">Richard  Marais</span>. </span><span class="cited-content_cbyCitation_article-title">BRAF Signaling and Targeted Therapies in Melanoma. </span><span class="cited-content_cbyCitation_journal-name">Hematology/Oncology Clinics of North America</span><span> <strong>2009,</strong> <em>23 </em>
                                    (3)
                                     , 529-545. <a href="https://doi.org/10.1016/j.hoc.2009.04.001" title="DOI URL">https://doi.org/10.1016/j.hoc.2009.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.hoc.2009.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.hoc.2009.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DHematology%252FOncology%2520Clinics%2520of%2520North%2520America%26atitle%3DBRAF%252BSignaling%252Band%252BTargeted%252BTherapies%252Bin%252BMelanoma%26aulast%3DDhomen%26aufirst%3DNathalie%26date%3D2009%26volume%3D23%26issue%3D3%26spage%3D529%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amelia  Manlove</span>, <span class="hlFld-ContribAuthor ">Michael P.  Groziak</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 6.2: Six-Membered Ring Systems: Diazines and Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2009,</strong>,, 375-414. <a href="https://doi.org/10.1016/S0959-6380(09)70040-6" title="DOI URL">https://doi.org/10.1016/S0959-6380(09)70040-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(09)70040-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2809%2970040-6%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B6.2%25253A%252BSix-Membered%252BRing%252BSystems%25253A%252BDiazines%252Band%252BBenzo%252BDerivatives%26aulast%3DManlove%26aufirst%3DAmelia%26date%3D2009%26spage%3D375%26epage%3D414%26pub%3DElsevier%26date%3D2009%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">O N  Ikediobi</span>. </span><span class="cited-content_cbyCitation_article-title">Somatic pharmacogenomics in cancer. </span><span class="cited-content_cbyCitation_journal-name">The Pharmacogenomics Journal</span><span> <strong>2008,</strong> <em>8 </em>
                                    (5)
                                     , 305-314. <a href="https://doi.org/10.1038/tpj.2008.8" title="DOI URL">https://doi.org/10.1038/tpj.2008.8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/tpj.2008.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Ftpj.2008.8%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Pharmacogenomics%2520Journal%26atitle%3DSomatic%252Bpharmacogenomics%252Bin%252Bcancer%26aulast%3DIkediobi%26aufirst%3DO%2BN%26date%3D2008%26date%3D2008%26volume%3D8%26issue%3D5%26spage%3D305%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0016.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0017.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(0)<sub>2</sub>dba<sub>3</sub>, BINAP, NaOtBu, toluene, 90 °C; (b) PdCl<sub>2</sub>·dppf:DCM 1:1, DME, Na<sub>2</sub>CO<sub>3</sub> 1M, 90 °C.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0018.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Route for the Synthesis of Compound <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ac<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, reflux; (b) 3-acetamidophenyl boronic acid, PdCl<sub>2</sub>·dppf:DCM 1:1, DME, Na<sub>2</sub>CO<sub>3</sub> 1M, 90 °C, microwave; (c) 3,4,5-trimethoxyaniline, Pd<sub>2</sub>(0)dba<sub>3</sub>, Xantphos, NaOtBu, toluene, 110 °C.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0019.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Route for Central-Core Modified Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3,5-dibromopyridine, Pd(0)<sub>2</sub>dba<sub>3</sub>, BINAP, NaOtBu, toluene, 90 °C; (b) PdCl<sub>2</sub>·dppf:DCM 1:1,DME, Na<sub>2</sub>CO<sub>3</sub> 1M, 90 °C.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0020.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Diamino Analogues<sup>a</sup>.</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) aminoaryl compounds, Pd(0)<sub>2</sub>dba<sub>3</sub>, 1,3-bis-(2,6-di-i-propylphenyl)-4,5-dihydroimidazolium tetrafluoroborate, KOtBu, dioxane, 100 °C, microwave.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/medium/jm-2007-00776b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0001.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-11/jm070776b/production/images/large/jm-2007-00776b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070776b&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KOtBu, DMF, 90 °C; (b) Pd(0)<sub>2</sub>dba<sub>3</sub>, dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino-biphenyl), NaOtBu, toluene, 90 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i107">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wellbrock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasarides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, R.</span><span> </span><span class="NLM_article-title">The RAF proteins take center stage</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">875</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm070776b&amp;key=10.1038%2Fnrm1498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm070776b&amp;key=15520807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm070776b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFemsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=875-885&author=C.+Wellbrockauthor=M.+Karasaridesauthor=R.+Marais&title=The+RAF+proteins+take+center+stage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The RAF proteins take center stage</span></div><div class="casAuthors">Wellbrock, Claudia; Karasarides, Maria; Marais, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">875-885</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since their discovery over 20 years ago, the RAF proteins have been intensely studied.  For most of that time, the focus of the field has been the C-RAF isoform and its role as an effector of the RAS proteins.  However, a report that implicates B-RAF in human cancer has highlighted the importance of all members of this protein kinase family and recent studies have uncovered intriguing new data relating to their complex regulation and biol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvN4GggcdfU7Vg90H21EOLACvtfcHk0lhAuNInKjRDVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFemsLs%253D&md5=95f0a579b4c852fbe80a54befb88b052</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm1498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1498%26sid%3Dliteratum%253Aachs%26aulast%3DWellbrock%26aufirst%3DC.%26aulast%3DKarasarides%26aufirst%3DM.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DThe%2520RAF%2520proteins%2520take%2520center%2520stage%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D875%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Davies, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bignell, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephen, P.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Mutation of the BRAF gene in human cancers</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">417</span> <span class="NLM_fpage">949</span> <span class="NLM_lpage">954</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=949-954&author=H.+Daviesauthor=G.+R.+Bignellauthor=C.+Coxauthor=P.+Stephen&title=Mutation+of+the+BRAF+gene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DBignell%26aufirst%3DG.%2BR.%26aulast%3DCox%26aufirst%3DC.%26aulast%3DStephen%26aufirst%3DP.%26atitle%3DMutation%2520of%2520the%2520BRAF%2520gene%2520in%2520human%2520cancers%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D949%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Tuveson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlyn, M.</span><span> </span><span class="NLM_article-title">BRAF as a potential therapeutic target in melanoma and other malignancies</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">95</span> <span class="NLM_lpage">98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=95-98&author=D.+A.+Tuvesonauthor=B.+L.+Weberauthor=M.+Herlyn&title=BRAF+as+a+potential+therapeutic+target+in+melanoma+and+other+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DWeber%26aufirst%3DB.%2BL.%26aulast%3DHerlyn%26aufirst%3DM.%26atitle%3DBRAF%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520melanoma%2520and%2520other%2520malignancies%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D4%26spage%3D95%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Garnett, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marais, R.</span><span> </span><span class="NLM_article-title">Guilty as charged: B-RAF is a human oncogene</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">313</span> <span class="NLM_lpage">319</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=313-319&author=M.+J.+Garnettauthor=R.+Marais&title=Guilty+as+charged%3A+B-RAF+is+a+human+oncogene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DMarais%26aufirst%3DR.%26atitle%3DGuilty%2520as%2520charged%253A%2520B-RAF%2520is%2520a%2520human%2520oncogene%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D4%26spage%3D313%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Chiloeches, A.; Marais, R.</span><span> </span><span class="NLM_article-title">Mitogen-activated protein kinase cascades as therapeutic targets in cancer</span>.  <span class="citation_source-book">Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins</span>; <span class="NLM_publisher-name">Humana Press Inc</span>.: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2002</span>; pp  <span class="NLM_fpage">179</span>− <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=179-206&author=A.+Chiloeches&author=R.+Marais&title=Targets+for+Cancer+Chemotherapy%3A+Transcription+Factors+and+Other+Nuclear+Proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChiloeches%26aufirst%3DA.%26atitle%3DMitogen-activated%2520protein%2520kinase%2520cascades%2520as%2520therapeutic%2520targets%2520in%2520cancer%26btitle%3DTargets%2520for%2520Cancer%2520Chemotherapy%253A%2520Transcription%2520Factors%2520and%2520Other%2520Nuclear%2520Proteins%26pub%3DHumana%2520Press%2520Inc%26date%3D2002%26spage%3D179%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity</span> <span class="citation_source-journal">Anti-Cancer Drug Des.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">1</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2001&pages=1-6&author=E.+Woodauthor=R.+M.+Crosbyauthor=S.+Dickersonauthor=S.+V.+Fryeauthor=R.+Griffin&title=A+prodrug+approach+to+the+design+of+cRaf1+kinase+inhibitors+with+improved+cellular+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DDickerson%26aufirst%3DS.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGriffin%26aufirst%3DR.%26atitle%3DA%2520prodrug%2520approach%2520to%2520the%2520design%2520of%2520cRaf1%2520kinase%2520inhibitors%2520with%2520improved%2520cellular%2520activity%26jtitle%3DAnti-Cancer%2520Drug%2520Des.%26date%3D2001%26volume%3D16%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hall-Jackson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyers, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, N.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Paradoxical activation of Raf by a novel Raf inhibitor</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">559</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm070776b&amp;key=10.1016%2FS1074-5521%2899%2980088-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm070776b&amp;key=10421767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm070776b&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVynsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=559-568&author=C.+A.+Hall-Jacksonauthor=P.+A.+Eyersauthor=P.+Cohenauthor=F.+T.+Boyleauthor=N.+Hewitt&title=Paradoxical+activation+of+Raf+by+a+novel+Raf+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Paradoxical activation of raf by a novel raf inhibitor</span></div><div class="casAuthors">Hall-Jackson, Clare A.; Eyers, Patrick A.; Cohen, Philip; Goedert, Michel; Boyle, F. Tom; Hewitt, Neil; Plant, Helen; Hedge, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">559-568</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Raf is a proto-oncogene that is activated in response to growth factors or phorbol esters, and is thought to activate MAP kinase kinase-1 (MKK1) and hence the classical MAP kinase (MAPK) cascade.  The compd. ZM 336372 is identified as a potent and specific inhibitor of Raf isoforms in vitro.  Paradoxically, exposure of cells to ZM 336372 induces > 100-fold activation of c-Raf (measured in the absence of compd.), but without triggering any activation of MKK1 or p42 MAPK/ERK2.  The ZM 336372-induced activation of c-Raf occurs without any increase in the GTP-loading of Ras and is not prevented by inhibition of the MAPK cascade, protein kinase C or phosphatidylinositide 3-kinase.  ZM 336372 does not prevent growth factor or phorbol ester induced activation of MKK1 or p42 MAPK/ERK2, or reverse the phenotype of Ras- or Raf-transformed cell lines.  The only other protein kinase inhibited by ZM 336372 out of 20 tested was SAPK2/p38.  Although ZM 336372 is structurally unrelated to SB 203580, a potent inhibitor of SAPK2/p38, the mutation of Thr106→Met made SAPK2/p38 insensitive to ZM 336372 as well as to SB 203580.  Raf appears to suppress its own activation by a novel feedback loop, such that inhibition is always counterbalanced by reactivation.  These observations imply that some agonists reported to trigger the cellular activation of c-Raf might actually be inhibitors of this enzyme, and that compds. which inhibit the kinase activity of Raf might not be useful as anticancer drugs.  The binding sites for ZM 336372 and SB 203580 on Raf and SAPK2/p38 are likely to overlap.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo23oQKXswmRbVg90H21EOLACvtfcHk0lj8KxArmwsnWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVynsbo%253D&md5=93aa7dbc301a6f798be138df3e5a075c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980088-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980088-X%26sid%3Dliteratum%253Aachs%26aulast%3DHall-Jackson%26aufirst%3DC.%2BA.%26aulast%3DEyers%26aufirst%3DP.%2BA.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DHewitt%26aufirst%3DN.%26atitle%3DParadoxical%2520activation%2520of%2520Raf%2520by%2520a%2520novel%2520Raf%2520inhibitor%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D559%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Wilhelm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNabola, A.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">64</span> <span class="NLM_fpage">7099</span> <span class="NLM_lpage">7109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7099-7109&author=S.+M.+Wilhelmauthor=C.+Carterauthor=L.+Y.+Tangauthor=D.+Wilkieauthor=A.+McNabola&title=BAY+43-9006+exhibits+broad+spectrum+oral+antitumor+activity+and+targets+the+RAF%2FMEK%2FERK+pathway+and+receptor+tyrosine+kinases+involved+in+tumor+progression+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%2BM.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DL.%2BY.%26aulast%3DWilkie%26aufirst%3DD.%26aulast%3DMcNabola%26aufirst%3DA.%26atitle%3DBAY%252043-9006%2520exhibits%2520broad%2520spectrum%2520oral%2520antitumor%2520activity%2520and%2520targets%2520the%2520RAF%252FMEK%252FERK%2520pathway%2520and%2520receptor%2520tyrosine%2520kinases%2520involved%2520in%2520tumor%2520progression%2520and%2520angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7099%26epage%3D7109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, L. E.</span><span> </span><span class="NLM_article-title">Raf pathway inhibition in oncology</span> <span class="citation_source-journal">Curr. Opin. Investig. Drugs</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">1436</span> <span class="NLM_lpage">1441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=1436-1441&author=G.+Bollagauthor=S.+Freemanauthor=G.+F.+Lyonsauthor=L.+E.+Post&title=Raf+pathway+inhibition+in+oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DFreeman%26aufirst%3DS.%26aulast%3DLyons%26aufirst%3DG.%2BF.%26aulast%3DPost%26aufirst%3DL.%2BE.%26atitle%3DRaf%2520pathway%2520inhibition%2520in%2520oncology%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2004%26volume%3D4%26spage%3D1436%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, S. M.</span><span> </span><span class="NLM_article-title">Recent advances in the research and development of RAF kinase inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">1071</span> <span class="NLM_lpage">1089</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm070776b&amp;key=10.2174%2F156802606777812077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm070776b&amp;key=16842147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm070776b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1071-1089&author=R.+A.+Smithauthor=J.+Dumasauthor=L.+Adnaneauthor=S.+M.+Wilhelm&title=Recent+advances+in+the+research+and+development+of+RAF+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the research and development of RAF kinase inhibitors</span></div><div class="casAuthors">Smith, Roger A.; Dumas, Jacques; Adnane, Lila; Wilhelm, Scott M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1071-1089</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The RAS-RAF-MEK-ERK signaling pathway (ERK pathway) plays a key role in tumorigenesis and cancer progression.  Mutations of RAS or B-RAF lead to a constitutive activation of the ERK pathway, which ultimately results in increased cell division, and cell survival.  This review article focuses on the recent literature related to ERK pathway inhibitors, with a particular emphasis on RAF kinase inhibitors.  Preclin. and clin. data for the RAF kinase inhibitor sorafenib (BAY 43-9006 tosylate), that was recently approved in the US for the treatment of advanced renal cell carcinoma, are also outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr4CQGGdqnEbVg90H21EOLACvtfcHk0lgLEeJFWp-qWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejt7o%253D&md5=3a31ae50cbb92d9c35b2df39589cbeba</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F156802606777812077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812077%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DAdnane%26aufirst%3DL.%26aulast%3DWilhelm%26aufirst%3DS.%2BM.%26atitle%3DRecent%2520advances%2520in%2520the%2520research%2520and%2520development%2520of%2520RAF%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1071%26epage%3D1089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Batt, D. B.; Bold, G.; Kim, S.; Ramsey, T. M.; Sabio, M. L.</span> <span class="citation_source-book">Use of Isoquinoline Derivatives for Treating Cancer and MAP Kinase Related Diseases</span>; <span class="NLM_publisher-name">Novartis AG</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>, <span class="NLM_year">2004</span>; p  <span class="NLM_fpage">85</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=85&author=D.+B.+Batt&author=G.+Bold&author=S.+Kim&author=T.+M.+Ramsey&author=M.+L.+Sabio&title=Use+of+Isoquinoline+Derivatives+for+Treating+Cancer+and+MAP+Kinase+Related+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBatt%26aufirst%3DD.%2BB.%26btitle%3DUse%2520of%2520Isoquinoline%2520Derivatives%2520for%2520Treating%2520Cancer%2520and%2520MAP%2520Kinase%2520Related%2520Diseases%26pub%3DNovartis%2520AG%26date%3D2004%26spage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Fink, C. A.; Perez, L. B.; Ramsey, T. M.; Yusuf, N.; Versace, R. W.</span><span class="NLM_etal"></span> <span class="citation_source-book">1,4-Disubstituted Isoquinoline Derivatives as RAF-Kinase Inhibitors Useful for the Treatment of Proliferative Diseases</span>; <span class="NLM_publisher-name">Novartis AG</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>, <span class="NLM_year">2005</span>; p  <span class="NLM_fpage">144</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=144&author=C.+A.+Fink&author=L.+B.+Perez&author=T.+M.+Ramsey&author=N.+Yusuf&author=R.+W.+Versace&title=1%2C4-Disubstituted+Isoquinoline+Derivatives+as+RAF-Kinase+Inhibitors+Useful+for+the+Treatment+of+Proliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFink%26aufirst%3DC.%2BA.%26btitle%3D1%252C4-Disubstituted%2520Isoquinoline%2520Derivatives%2520as%2520RAF-Kinase%2520Inhibitors%2520Useful%2520for%2520the%2520Treatment%2520of%2520Proliferative%2520Diseases%26pub%3DNovartis%2520AG%26date%3D2005%26spage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Takle, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">The identification of potent and selective imidazole-based inhibitors of B-RAF kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">378</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=378-381&author=A.+K.+Takleauthor=M.+J.+B.+Brownauthor=S.+Daviesauthor=D.+K.+Deanauthor=G.+Francis&title=The+identification+of+potent+and+selective+imidazole-based+inhibitors+of+B-RAF+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DBrown%26aufirst%3DM.%2BJ.%2BB.%26aulast%3DDavies%26aufirst%3DS.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DFrancis%26aufirst%3DG.%26atitle%3DThe%2520identification%2520of%2520potent%2520and%2520selective%2520imidazole-based%2520inhibitors%2520of%2520B-RAF%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D378%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">King, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batorsky, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, H. T.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">66</span> <span class="NLM_fpage">11100</span> <span class="NLM_lpage">11105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=11100-11105&author=A.+J.+Kingauthor=D.+R.+Patrickauthor=R.+S.+Batorskyauthor=M.+L.+Hoauthor=H.+T.+Do&title=Demonstration+of+a+genetic+therapeutic+index+for+tumors+expressing+oncogenic+BRAF+by+the+kinase+inhibitor+SB-590885"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DA.%2BJ.%26aulast%3DPatrick%26aufirst%3DD.%2BR.%26aulast%3DBatorsky%26aufirst%3DR.%2BS.%26aulast%3DHo%26aufirst%3DM.%2BL.%26aulast%3DDo%26aufirst%3DH.%2BT.%26atitle%3DDemonstration%2520of%2520a%2520genetic%2520therapeutic%2520index%2520for%2520tumors%2520expressing%2520oncogenic%2520BRAF%2520by%2520the%2520kinase%2520inhibitor%2520SB-590885%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D11100%26epage%3D11105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ahmad, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, T.</span><span> </span><span class="NLM_article-title">Kinase inhibition with BAY 43-9006 in renal cell carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">10</span> <span class="NLM_fpage">6388S</span> <span class="NLM_lpage">6392S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=6388S-6392S&author=T.+Ahmadauthor=T.+Eisen&title=Kinase+inhibition+with+BAY+43-9006+in+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DT.%26aulast%3DEisen%26aufirst%3DT.%26atitle%3DKinase%2520inhibition%2520with%2520BAY%252043-9006%2520in%2520renal%2520cell%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D6388S%26epage%3D6392S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Niculescu-Duvaz, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittaker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedlos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Novel inhibitors of B-RAF based on a disubstituted pyrazine scaffold. Generation of a nanomolar lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">407</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050983g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=407-416&author=I.+Niculescu-Duvazauthor=E.+Romanauthor=S.+R.+Wittakerauthor=F.+Friedlosauthor=R.+Kirk&title=Novel+inhibitors+of+B-RAF+based+on+a+disubstituted+pyrazine+scaffold.+Generation+of+a+nanomolar+lead"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm050983g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050983g%26sid%3Dliteratum%253Aachs%26aulast%3DNiculescu-Duvaz%26aufirst%3DI.%26aulast%3DRoman%26aufirst%3DE.%26aulast%3DWittaker%26aufirst%3DS.%2BR.%26aulast%3DFriedlos%26aufirst%3DF.%26aulast%3DKirk%26aufirst%3DR.%26atitle%3DNovel%2520inhibitors%2520of%2520B-RAF%2520based%2520on%2520a%2520disubstituted%2520pyrazine%2520scaffold.%2520Generation%2520of%2520a%2520nanomolar%2520lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Wan, P. T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnett, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niculescu-Duvaz, D.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Mechanism of activation of of the RAF/ERK signaling pathway by oncogenic mutations of B-RAF</span> <span class="citation_source-journal">Cell</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">116</span> <span class="NLM_fpage">855</span> <span class="NLM_lpage">867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=855-867&author=P.+T.+C.+Wanauthor=M.+J.+Garnettauthor=M.+S.+Roeauthor=S.+Leeauthor=D.+Niculescu-Duvaz&title=Mechanism+of+activation+of+of+the+RAF%2FERK+signaling+pathway+by+oncogenic+mutations+of+B-RAF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DP.%2BT.%2BC.%26aulast%3DGarnett%26aufirst%3DM.%2BJ.%26aulast%3DRoe%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DNiculescu-Duvaz%26aufirst%3DD.%26atitle%3DMechanism%2520of%2520activation%2520of%2520of%2520the%2520RAF%252FERK%2520signaling%2520pathway%2520by%2520oncogenic%2520mutations%2520of%2520B-RAF%26jtitle%3DCell%26date%3D2004%26volume%3D116%26spage%3D855%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Liao, J. J.-L.</span><span> </span><span class="NLM_article-title">Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">409</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm070776b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J.+J.-L.+Liao&title=Molecular+recognition+of+protein+kinase+binding+pockets+for+design+of+potent+and+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lgZi193xcji4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.-L.%26atitle%3DMolecular%2520recognition%2520of%2520protein%2520kinase%2520binding%2520pockets%2520for%2520design%2520of%2520potent%2520and%2520selective%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Wolfe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadighi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Simple, efficient catalyst system for the palladium-catalyzed amination of aryl chlorides, bromides and triflates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">65</span> <span class="NLM_fpage">1158</span> <span class="NLM_lpage">1174</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo991699y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=1158-1174&author=J.+P.+Wolfeauthor=H.+Tomoriauthor=J.+P.+Sadighiauthor=J.+Yinauthor=S.+L.+Buchwald&title=Simple%2C+efficient+catalyst+system+for+the+palladium-catalyzed+amination+of+aryl+chlorides%2C+bromides+and+triflates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo991699y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo991699y%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26aulast%3DTomori%26aufirst%3DH.%26aulast%3DSadighi%26aufirst%3DJ.%2BP.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DSimple%252C%2520efficient%2520catalyst%2520system%2520for%2520the%2520palladium-catalyzed%2520amination%2520of%2520aryl%2520chlorides%252C%2520bromides%2520and%2520triflates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D1158%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Grasa, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viciu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, S. P.</span><span> </span><span class="NLM_article-title">Amination reaction of aryl halides with nitrogen-containing reagents mediated by palladium/imidazolium salts</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">66</span> <span class="NLM_fpage">7729</span> <span class="NLM_lpage">7737</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo010613%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=7729-7737&author=G.+A.+Grasaauthor=M.+S.+Viciuauthor=J.+Huangauthor=S.+P.+Nolan&title=Amination+reaction+of+aryl+halides+with+nitrogen-containing+reagents+mediated+by+palladium%2Fimidazolium+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo010613%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010613%252B%26sid%3Dliteratum%253Aachs%26aulast%3DGrasa%26aufirst%3DG.%2BA.%26aulast%3DViciu%26aufirst%3DM.%2BS.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DNolan%26aufirst%3DS.%2BP.%26atitle%3DAmination%2520reaction%2520of%2520aryl%2520halides%2520with%2520nitrogen-containing%2520reagents%2520mediated%2520by%2520palladium%252Fimidazolium%2520salts%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D7729%26epage%3D7737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kotha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">khashinath, D.</span><span> </span><span class="NLM_article-title">Recent applications of the Suzuki−Miyaura cross coupling reactions in organic synthesis</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">58</span> <span class="NLM_fpage">9633</span> <span class="NLM_lpage">9695</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=9633-9695&author=S.+Kothaauthor=K.+Lahiriauthor=D.+khashinath&title=Recent+applications+of+the+Suzuki%E2%88%92Miyaura+cross+coupling+reactions+in+organic+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKotha%26aufirst%3DS.%26aulast%3DLahiri%26aufirst%3DK.%26aulast%3Dkhashinath%26aufirst%3DD.%26atitle%3DRecent%2520applications%2520of%2520the%2520Suzuki%25E2%2588%2592Miyaura%2520cross%2520coupling%2520reactions%2520in%2520organic%2520synthesis%26jtitle%3DTetrahedron%26date%3D2002%26volume%3D58%26spage%3D9633%26epage%3D9695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Littke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, G. C.</span><span> </span><span class="NLM_article-title">Palladium catalysed coupling reaction of aryl chlorides</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">41</span> <span class="NLM_fpage">4176</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=4176-4211&author=A.+Littkeauthor=G.+C.+Fu&title=Palladium+catalysed+coupling+reaction+of+aryl+chlorides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLittke%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DG.%2BC.%26atitle%3DPalladium%2520catalysed%2520coupling%2520reaction%2520of%2520aryl%2520chlorides%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D4176%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witteking, M.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against Imatinib-resistant ABL mutants</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">66</span> <span class="NLM_fpage">5790</span> <span class="NLM_lpage">5797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=5790-5797&author=J.+S.+Tokarskiauthor=J.+A.+Newittauthor=C.+Y.+J.+Changauthor=J.+D.+Chengauthor=M.+Witteking&title=The+structure+of+Dasatinib+%28BMS-354825%29+bound+to+activated+ABL+kinase+domain+elucidates+its+inhibitory+activity+against+Imatinib-resistant+ABL+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DChang%26aufirst%3DC.%2BY.%2BJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DWitteking%26aufirst%3DM.%26atitle%3DThe%2520structure%2520of%2520Dasatinib%2520%2528BMS-354825%2529%2520bound%2520to%2520activated%2520ABL%2520kinase%2520domain%2520elucidates%2520its%2520inhibitory%2520activity%2520against%2520Imatinib-resistant%2520ABL%2520mutants%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D5790%26epage%3D5797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-note1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i106"><a href="/doi/suppl/10.1021/jm070776b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53322"></div></div></div></div></div><hr /></hr><p class="last">Tables of purity and HPLC traces for final compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm070776b/suppl_file/jm070776b-file013.pdf">jm070776b-file013.pdf (18.52 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm070776b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm070776b%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm070776b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                255KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a95b6fc73d42","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
